eagle-i eagle-i Network Shared Resource Repositoryeagle-i Network Shared Resource Repository
See it in Search

WiCell

Summary:

Headquartered in Madison, Wisconsin, WiCell is a supporting organization of the University of Wisconsin–Madison, a world leader in the area of human pluripotent stem cell research. WiCell is a nonprofit organization established in 1999 to advance the science of stem cells. The global leader in cell banking, cytogenetic testing and distribution of stem cell lines, WiCell builds on these core strengths by also providing clinical grade pluripotent stem cell lines, quality control testing and cell banking services.

Affiliations:

Resources:

Protocols

Reagents

  • CREM001i-bBU1C2 ( Induced pluripotent stem cell line )

  • CREM002i-BU2C10 ( Induced pluripotent stem cell line )

  • CREM003i-BU3C2 ( Induced pluripotent stem cell line )

  • CREM004i-SS2-1 ( Induced pluripotent stem cell line )

  • CREM006i-SS4-1 ( Induced pluripotent stem cell line )

  • CREM007i-SS5-1 ( Induced pluripotent stem cell line )

  • CREM008i-SS6-1 ( Induced pluripotent stem cell line )

  • CREM009i-SS8-2 ( Induced pluripotent stem cell line )

  • CREM010i-SS9-1 ( Induced pluripotent stem cell line )

  • CREM012i-SS13-1 ( Induced pluripotent stem cell line )

  • CREM013i-SS14-1 ( Induced pluripotent stem cell line )

  • CREM014i-SS15-1 ( Induced pluripotent stem cell line )

  • CREM015i-SS16-1 ( Induced pluripotent stem cell line )

  • CREM016i-SS18-1 ( Induced pluripotent stem cell line )

  • CREM017i-SS19-1 ( Induced pluripotent stem cell line )

  • CREM018i-SS24-1 ( Induced pluripotent stem cell line )

  • CREM019i-SS25-1 ( Induced pluripotent stem cell line )

  • CREM020i-SS28-1 ( Induced pluripotent stem cell line )

  • CREM021i-SS29-1 ( Induced pluripotent stem cell line )

  • CREM022i-SS32-1 ( Induced pluripotent stem cell line )

  • CREM023i-SS35-1 ( Induced pluripotent stem cell line )

  • CREM024i-SS36-1 ( Induced pluripotent stem cell line )

  • CREM025i-SS37-1 ( Induced pluripotent stem cell line )

  • CREM026i-SS38-1 ( Induced pluripotent stem cell line )

  • CREM027i-SS41-1 ( Induced pluripotent stem cell line )

  • CREM028i-SS43-2 ( Induced pluripotent stem cell line )

  • CREM029i-SS44-1 ( Induced pluripotent stem cell line )

  • CREM030i-SS45-1 ( Induced pluripotent stem cell line )

  • CREM031i-SS47-1 ( Induced pluripotent stem cell line )

  • CREM032i-SS48-1 ( Induced pluripotent stem cell line )

  • CREM033i-SS49-1 ( Induced pluripotent stem cell line )

  • CREM034i-SA5-1 ( Induced pluripotent stem cell line )

  • CREM035i-SA36-1 ( Induced pluripotent stem cell line )

  • CREM036i-SA40-1 ( Induced pluripotent stem cell line )

  • CREM037i-SA53-1 ( Induced pluripotent stem cell line )

  • CREM038i-SA64-1 ( Induced pluripotent stem cell line )

  • CREM041i-SA208-2 ( Induced pluripotent stem cell line )

  • CREM042i-SA209-1 ( Induced pluripotent stem cell line )

  • CREM044i-SA50-1 ( Induced pluripotent stem cell line )

  • CREM045i-SA106-1 ( Induced pluripotent stem cell line )

  • CREM046i-SA138-1 ( Induced pluripotent stem cell line )

  • CREM047i-SA170-1 ( Induced pluripotent stem cell line )

  • IISH1i-BM1 ( Induced pluripotent stem cell line )

    Feeder Independent iPS cell line derived from bone marrow cells

  • IISH2i-BM9 ( Induced pluripotent stem cell line )

    Feeder Independent iPS cell line derived from bone marrow cells

  • IISH3i-CB6 ( Induced pluripotent stem cell line )

    Feeder Independent iPS cell line derived from Cord blood cell

  • IISH6i-CML17 ( Induced pluripotent stem cell line )

    Induced pluripotent stem (iPS) cell line. Genetic abnormalities consistent with chronic myloid leukemia.

  • iPS DF19-9-11T.H ( Induced pluripotent stem cell line )

    Induced pluripotent stem (iPS) cell line derived vector free from foreskin fibroblasts.

  • iPS DF19-9-7T ( Induced pluripotent stem cell line )

    Induced pluripotent stem (iPS) cell line derived vector free from foreskin fibroblasts.

  • iPS DF4-3-7T.A ( Induced pluripotent stem cell line )

    Induced pluripotent stem (iPS) cell line derived vector free from foreskin fibroblasts.

  • iPS DF6-9-9T.B ( Induced pluripotent stem cell line )

    Induced pluripotent stem (iPS) cell line derived vector free from foreskin fibroblasts.

  • iPS(Foreskin)-1 ( Induced pluripotent stem cell line )

    Induced pluripotent stem (iPS) cell line derived from foreskin fibroblasts.

  • iPS(Foreskin)-2 ( Induced pluripotent stem cell line )

    Induced pluripotent stem (iPS) cell line derived from foreskin fibroblasts.

  • iPS(Foreskin)-3 ( Induced pluripotent stem cell line )

    Induced pluripotent stem (iPS) cell line derived from foreskin fibroblasts.

  • iPS(Foreskin)-4 ( Induced pluripotent stem cell line )

    Induced pluripotent stem (iPS) cell line derived from foreskin fibroblasts.

  • iPS(IMR90)-1 ( Induced pluripotent stem cell line )

    Induced pluripotent stem (iPS) cell line derived from IMR90 cells.

  • iPS(IMR90)-2 ( Induced pluripotent stem cell line )

    Induced pluripotent stem (iPS) cell line derived from IMR90 cells.

  • iPS(IMR90)-3 ( Induced pluripotent stem cell line )

    Induced pluripotent stem (iPS) cell line derived from IMR90 cells.

  • iPS(IMR90)-4 ( Induced pluripotent stem cell line )

    Induced pluripotent stem (iPS) cell line derived from IMR90 cells.

  • JFHZ1 ( Induced pluripotent stem cell line )

    Carrier of Limb-Girdle Muscular Dystrophy

  • JFHZ2 ( Induced pluripotent stem cell line )

    Heterozygous Carrier of Limb-Girdle Muscular Dystrophy

  • JFHZ3 ( Induced pluripotent stem cell line )

    Carrier of Limb-Girdle Muscular Dystrophy

  • JFMD1 ( Induced pluripotent stem cell line )

    Limb-Girdle Muscular Dystrophy LGMD2B

  • JFMD2 ( Induced pluripotent stem cell line )

    Limb-Girdle Muscular Dystrophy LGMD2B

  • JFMD3 ( Induced pluripotent stem cell line )

    Limb-Girdle Muscular Dystrophy LGMD2B

  • JFMD4 ( Induced pluripotent stem cell line )

    Limb-Girdle Muscular Dystrophy LGMD2B

  • JFMD5 ( Induced pluripotent stem cell line )

    Limb-Girdle Muscular Dystrophy LGMD2B

  • JFNY1 ( Induced pluripotent stem cell line )

    Limb-Girdle Muscular Dystrophy

  • JFRBi1 ( Induced pluripotent stem cell line )

    Limb-Girdle Muscular Dystrophy LGMD2B

  • JFRBi2 ( Induced pluripotent stem cell line )

    Limb-Girdle Muscular Dystrophy LGMD2B

  • JFRBi3 ( Induced pluripotent stem cell line )

    Limb-Girdle Muscular Dystrophy LGMD2B

  • JFRBi4 ( Induced pluripotent stem cell line )

    Limb-Girdle Muscular Dystrophy LGMD2B

  • JFWT1 ( Induced pluripotent stem cell line )

    WT control for Limb-Girdle Muscular Dystrophy

  • JFWT2 ( Induced pluripotent stem cell line )

    WT control for Limb-Girdle Muscular Dystrophy

  • JFWT3 ( Induced pluripotent stem cell line )

    WT control for Limb-Girdle Muscular Dystrophy

  • JHU001i ( Induced pluripotent stem cell line )

  • JHU002i-1 ( Induced pluripotent stem cell line )

  • JHU004i-2 ( Induced pluripotent stem cell line )

  • JHU012i-2 ( Induced pluripotent stem cell line )

  • JHU013i-2 ( Induced pluripotent stem cell line )

  • JHU017i ( Induced pluripotent stem cell line )

  • JHU018i ( Induced pluripotent stem cell line )

  • JHU019i ( Induced pluripotent stem cell line )

  • JHU022i ( Induced pluripotent stem cell line )

  • JHU023i ( Induced pluripotent stem cell line )

  • JHU024i ( Induced pluripotent stem cell line )

  • JHU027i ( Induced pluripotent stem cell line )

  • JHU032i ( Induced pluripotent stem cell line )

  • JHU033i ( Induced pluripotent stem cell line )

  • JHU035i ( Induced pluripotent stem cell line )

  • JHU036i ( Induced pluripotent stem cell line )

  • JHU037i ( Induced pluripotent stem cell line )

  • JHU038i ( Induced pluripotent stem cell line )

  • JHU039i ( Induced pluripotent stem cell line )

  • JHU040i ( Induced pluripotent stem cell line )

  • JHU042i ( Induced pluripotent stem cell line )

  • JHU043i ( Induced pluripotent stem cell line )

  • JHU044i ( Induced pluripotent stem cell line )

  • JHU045i ( Induced pluripotent stem cell line )

  • JHU047i ( Induced pluripotent stem cell line )

  • JHU048i ( Induced pluripotent stem cell line )

  • JHU049i ( Induced pluripotent stem cell line )

  • JHU050i ( Induced pluripotent stem cell line )

  • JHU052i ( Induced pluripotent stem cell line )

  • JHU053i ( Induced pluripotent stem cell line )

  • JHU054i ( Induced pluripotent stem cell line )

  • JHU055i ( Induced pluripotent stem cell line )

  • JHU056i ( Induced pluripotent stem cell line )

  • JHU057i ( Induced pluripotent stem cell line )

  • JHU058i ( Induced pluripotent stem cell line )

  • JHU060i-2 ( Induced pluripotent stem cell line )

  • JHU062i ( Induced pluripotent stem cell line )

  • JHU063i ( Induced pluripotent stem cell line )

  • JHU064i ( Induced pluripotent stem cell line )

  • JHU065i ( Induced pluripotent stem cell line )

  • JHU066i ( Induced pluripotent stem cell line )

  • JHU067i ( Induced pluripotent stem cell line )

  • JHU070i ( Induced pluripotent stem cell line )

  • JHU071i ( Induced pluripotent stem cell line )

  • JHU072i ( Induced pluripotent stem cell line )

  • JHU073i ( Induced pluripotent stem cell line )

  • JHU074i ( Induced pluripotent stem cell line )

  • JHU075i ( Induced pluripotent stem cell line )

  • JHU077i ( Induced pluripotent stem cell line )

  • JHU078i ( Induced pluripotent stem cell line )

  • JHU079i ( Induced pluripotent stem cell line )

  • JHU080i ( Induced pluripotent stem cell line )

  • JHU081i ( Induced pluripotent stem cell line )

  • JHU082i ( Induced pluripotent stem cell line )

  • JHU083i ( Induced pluripotent stem cell line )

  • JHU084i ( Induced pluripotent stem cell line )

  • JHU085i ( Induced pluripotent stem cell line )

  • JHU086i ( Induced pluripotent stem cell line )

  • JHU087i ( Induced pluripotent stem cell line )

  • JHU088i ( Induced pluripotent stem cell line )

  • JHU089i ( Induced pluripotent stem cell line )

  • JHU090i ( Induced pluripotent stem cell line )

  • JHU091i ( Induced pluripotent stem cell line )

  • JHU093i ( Induced pluripotent stem cell line )

  • JHU094i ( Induced pluripotent stem cell line )

  • JHU095i ( Induced pluripotent stem cell line )

  • JHU096i ( Induced pluripotent stem cell line )

  • JHU097i ( Induced pluripotent stem cell line )

  • JHU098i ( Induced pluripotent stem cell line )

  • JHU099i ( Induced pluripotent stem cell line )

  • JHU100i ( Induced pluripotent stem cell line )

  • JHU101i ( Induced pluripotent stem cell line )

  • JHU102i ( Induced pluripotent stem cell line )

  • JHU103i ( Induced pluripotent stem cell line )

  • JHU104i ( Induced pluripotent stem cell line )

  • JHU105i ( Induced pluripotent stem cell line )

  • JHU106i ( Induced pluripotent stem cell line )

  • JHU107i ( Induced pluripotent stem cell line )

  • JHU108i ( Induced pluripotent stem cell line )

  • JHU111i ( Induced pluripotent stem cell line )

  • JHU114i ( Induced pluripotent stem cell line )

  • JHU115i ( Induced pluripotent stem cell line )

  • JHU116i ( Induced pluripotent stem cell line )

  • JHU117i ( Induced pluripotent stem cell line )

  • JHU119i ( Induced pluripotent stem cell line )

  • JHU121i ( Induced pluripotent stem cell line )

  • JHU122i ( Induced pluripotent stem cell line )

  • JHU123i ( Induced pluripotent stem cell line )

  • JHU124i ( Induced pluripotent stem cell line )

  • JHU125i ( Induced pluripotent stem cell line )

  • JHU126i ( Induced pluripotent stem cell line )

  • JHU127i ( Induced pluripotent stem cell line )

  • JHU128i ( Induced pluripotent stem cell line )

  • JHU129i ( Induced pluripotent stem cell line )

  • JHU130i ( Induced pluripotent stem cell line )

  • JHU131i ( Induced pluripotent stem cell line )

  • JHU132i ( Induced pluripotent stem cell line )

  • JHU133i ( Induced pluripotent stem cell line )

  • JHU139i ( Induced pluripotent stem cell line )

  • JHU140i ( Induced pluripotent stem cell line )

  • JHU141i ( Induced pluripotent stem cell line )

  • JHU142i ( Induced pluripotent stem cell line )

  • JHU143i ( Induced pluripotent stem cell line )

  • JHU145i ( Induced pluripotent stem cell line )

  • JHU146i ( Induced pluripotent stem cell line )

  • JHU148i ( Induced pluripotent stem cell line )

  • JHU149i ( Induced pluripotent stem cell line )

  • JHU150i ( Induced pluripotent stem cell line )

  • JHU151i ( Induced pluripotent stem cell line )

  • JHU152i ( Induced pluripotent stem cell line )

  • JHU153i ( Induced pluripotent stem cell line )

  • JHU154i ( Induced pluripotent stem cell line )

  • JHU155i ( Induced pluripotent stem cell line )

  • JHU156i ( Induced pluripotent stem cell line )

  • JHU157i ( Induced pluripotent stem cell line )

  • JHU158i ( Induced pluripotent stem cell line )

  • JHU159i ( Induced pluripotent stem cell line )

  • JHU160i ( Induced pluripotent stem cell line )

  • JHU162i ( Induced pluripotent stem cell line )

  • JHU163i ( Induced pluripotent stem cell line )

  • JHU164i ( Induced pluripotent stem cell line )

  • JHU165i ( Induced pluripotent stem cell line )

  • JHU166i ( Induced pluripotent stem cell line )

  • JHU167i ( Induced pluripotent stem cell line )

  • JHU170i ( Induced pluripotent stem cell line )

  • JHU171i ( Induced pluripotent stem cell line )

  • JHU172i ( Induced pluripotent stem cell line )

  • JHU173i ( Induced pluripotent stem cell line )

  • JHU174i ( Induced pluripotent stem cell line )

  • JHU176i ( Induced pluripotent stem cell line )

  • JHU177i ( Induced pluripotent stem cell line )

  • JHU178i ( Induced pluripotent stem cell line )

  • JHU180i ( Induced pluripotent stem cell line )

  • JHU181i ( Induced pluripotent stem cell line )

  • JHU183i ( Induced pluripotent stem cell line )

  • JHU184i ( Induced pluripotent stem cell line )

  • JHU185i ( Induced pluripotent stem cell line )

  • JHU186i ( Induced pluripotent stem cell line )

  • JHU187i ( Induced pluripotent stem cell line )

  • JHU188i ( Induced pluripotent stem cell line )

  • JHU189i ( Induced pluripotent stem cell line )

  • JHU190i ( Induced pluripotent stem cell line )

  • JHU191i ( Induced pluripotent stem cell line )

  • JHU192i ( Induced pluripotent stem cell line )

  • JHU194i ( Induced pluripotent stem cell line )

  • JHU196i ( Induced pluripotent stem cell line )

  • JHU197i ( Induced pluripotent stem cell line )

  • JHU198i ( Induced pluripotent stem cell line )

  • JHU199i ( Induced pluripotent stem cell line )

  • JHU200i ( Induced pluripotent stem cell line )

  • JHU201i ( Induced pluripotent stem cell line )

  • JHU203i ( Induced pluripotent stem cell line )

  • JHU204i ( Induced pluripotent stem cell line )

  • JHU205i ( Induced pluripotent stem cell line )

  • JHU206i ( Induced pluripotent stem cell line )

  • JHU207i ( Induced pluripotent stem cell line )

  • JHU208i ( Induced pluripotent stem cell line )

  • JHU209i ( Induced pluripotent stem cell line )

  • JHU210i ( Induced pluripotent stem cell line )

  • JHU214i ( Induced pluripotent stem cell line )

  • JHU215i ( Induced pluripotent stem cell line )

  • JHU216i ( Induced pluripotent stem cell line )

  • JHU217i ( Induced pluripotent stem cell line )

  • JHU218i ( Induced pluripotent stem cell line )

  • JHU219i ( Induced pluripotent stem cell line )

  • JHU220i ( Induced pluripotent stem cell line )

  • JHU221i ( Induced pluripotent stem cell line )

  • JHU222i ( Induced pluripotent stem cell line )

  • JHU224i ( Induced pluripotent stem cell line )

  • JHU225i ( Induced pluripotent stem cell line )

  • JHU226i ( Induced pluripotent stem cell line )

  • JHU227i ( Induced pluripotent stem cell line )

  • JHU228i ( Induced pluripotent stem cell line )

  • JHU229i ( Induced pluripotent stem cell line )

  • JHU230i ( Induced pluripotent stem cell line )

  • JHU231i ( Induced pluripotent stem cell line )

  • JHU232i ( Induced pluripotent stem cell line )

  • JHU233i ( Induced pluripotent stem cell line )

  • JHU234i ( Induced pluripotent stem cell line )

  • JHU235i ( Induced pluripotent stem cell line )

  • JHU236i ( Induced pluripotent stem cell line )

  • JHU237i ( Induced pluripotent stem cell line )

  • JHU238i ( Induced pluripotent stem cell line )

  • JHU240i ( Induced pluripotent stem cell line )

  • JHU242i ( Induced pluripotent stem cell line )

  • JHU243i ( Induced pluripotent stem cell line )

  • JHU244i ( Induced pluripotent stem cell line )

  • JHU245i ( Induced pluripotent stem cell line )

  • JHU246i ( Induced pluripotent stem cell line )

  • JHU247i ( Induced pluripotent stem cell line )

  • JHU248i ( Induced pluripotent stem cell line )

  • JHU250i ( Induced pluripotent stem cell line )

  • JHU251i ( Induced pluripotent stem cell line )

  • JHU252i ( Induced pluripotent stem cell line )

  • JHU253i ( Induced pluripotent stem cell line )

  • JHU255i ( Induced pluripotent stem cell line )

  • JHU256i ( Induced pluripotent stem cell line )

  • JHU257i ( Induced pluripotent stem cell line )

  • JHU259i ( Induced pluripotent stem cell line )

  • MIRJT6i-mND1-4 ( Induced pluripotent stem cell line )

    Feeder independent. NIH iPS control cell line mND2-0. Induced pluripotent stem (iPS) cell line derived vector free in defined conditions (E8/Vitronectin) from foreskin fibroblasts.

  • MIRJT7i-mND2-0 ( Induced pluripotent stem cell line )

    Feeder independent. NIH iPS control cell line mND2-0. Induced pluripotent stem (iPS) cell line derived vector free in defined conditions (E8/Vitronectin) from foreskin fibroblasts.

  • Penn001i-87-2 ( Induced pluripotent stem cell line )

  • Penn002i-442-1 ( Induced pluripotent stem cell line )

  • Penn003i-661-4 ( Induced pluripotent stem cell line )

  • Penn004i-277-1 ( Induced pluripotent stem cell line )

  • Penn005i-35-3 ( Induced pluripotent stem cell line )

  • Penn006i-149-1 ( Induced pluripotent stem cell line )

  • Penn007i-765-3 ( Induced pluripotent stem cell line )

  • Penn008i-77-5 ( Induced pluripotent stem cell line )

  • Penn009i-57-52 ( Induced pluripotent stem cell line )

  • Penn010i-486-2 ( Induced pluripotent stem cell line )

  • Penn011i-719-2 ( Induced pluripotent stem cell line )

  • Penn012i-93-2 ( Induced pluripotent stem cell line )

  • Penn013i-72-1 ( Induced pluripotent stem cell line )

  • Penn014i-37-3 ( Induced pluripotent stem cell line )

  • Penn015i-668-5 ( Induced pluripotent stem cell line )

  • Penn016i-821-1 ( Induced pluripotent stem cell line )

  • Penn017i-638-2 ( Induced pluripotent stem cell line )

  • Penn018i-487-4 ( Induced pluripotent stem cell line )

  • Penn019i-136-2 ( Induced pluripotent stem cell line )

  • Penn020i-588-6 ( Induced pluripotent stem cell line )

  • Penn021i-749-4 ( Induced pluripotent stem cell line )

  • Penn022i-89-1 ( Induced pluripotent stem cell line )

  • Penn023i-82-1 ( Induced pluripotent stem cell line )

  • Penn024i-370-3 ( Induced pluripotent stem cell line )

  • Penn025i-71-58 ( Induced pluripotent stem cell line )

  • Penn026i-124-1 ( Induced pluripotent stem cell line )

  • Penn027i-40-2 ( Induced pluripotent stem cell line )

  • Penn028i-637-2 ( Induced pluripotent stem cell line )

  • Penn029i-752-3 ( Induced pluripotent stem cell line )

  • Penn030i-384-4 ( Induced pluripotent stem cell line )

  • Penn031i-56-1 ( Induced pluripotent stem cell line )

  • Penn032i-15-5 ( Induced pluripotent stem cell line )

  • Penn033i-182-2 ( Induced pluripotent stem cell line )

  • Penn034i-322-1 ( Induced pluripotent stem cell line )

  • Penn035i-746-3 ( Induced pluripotent stem cell line )

  • Penn036i-286-3 ( Induced pluripotent stem cell line )

  • Penn037i-90-3 ( Induced pluripotent stem cell line )

  • Penn038i-366-6 ( Induced pluripotent stem cell line )

  • Penn039i-63-1 ( Induced pluripotent stem cell line )

  • Penn040i-134-2 ( Induced pluripotent stem cell line )

  • Penn041i-177-46 ( Induced pluripotent stem cell line )

  • Penn042i-258-12 ( Induced pluripotent stem cell line )

  • Penn043i-633-3 ( Induced pluripotent stem cell line )

  • Penn044i-51-1 ( Induced pluripotent stem cell line )

  • Penn045i-25-12 ( Induced pluripotent stem cell line )

  • Penn046i-271-1 ( Induced pluripotent stem cell line )

  • Penn047i-254-60 ( Induced pluripotent stem cell line )

  • Penn048i-41-6 ( Induced pluripotent stem cell line )

  • Penn049i-334-8 ( Induced pluripotent stem cell line )

  • Penn050i-245-10 ( Induced pluripotent stem cell line )

  • Penn051i-108-1 ( Induced pluripotent stem cell line )

  • Penn052i-444-2 ( Induced pluripotent stem cell line )

  • Penn053i-292-3 ( Induced pluripotent stem cell line )

  • Penn054i-225-33 ( Induced pluripotent stem cell line )

  • Penn055i-106-2 ( Induced pluripotent stem cell line )

  • Penn056i-1-1 ( Induced pluripotent stem cell line )

  • Penn057i-427-3 ( Induced pluripotent stem cell line )

  • Penn058i-285-3 ( Induced pluripotent stem cell line )

  • Penn059i-555-1 ( Induced pluripotent stem cell line )

  • Penn060i-23-1 ( Induced pluripotent stem cell line )

  • Penn061i-821-2 ( Induced pluripotent stem cell line )

  • Penn062i-278-2 ( Induced pluripotent stem cell line )

  • Penn063i-114-1 ( Induced pluripotent stem cell line )

  • Penn064i-22-2 ( Induced pluripotent stem cell line )

  • Penn065i-553-2 ( Induced pluripotent stem cell line )

  • Penn066i-427-6 ( Induced pluripotent stem cell line )

  • Penn067i-312-1 ( Induced pluripotent stem cell line )

  • Penn068i-697-3 ( Induced pluripotent stem cell line )

  • Penn069i-60-1 ( Induced pluripotent stem cell line )

  • Penn070i-408-1 ( Induced pluripotent stem cell line )

  • Penn071i-216-13 ( Induced pluripotent stem cell line )

  • Penn072i-187-3 ( Induced pluripotent stem cell line )

  • Penn073i-133-8 ( Induced pluripotent stem cell line )

  • Penn074i-415-3 ( Induced pluripotent stem cell line )

  • Penn075i-309-1 ( Induced pluripotent stem cell line )

  • Penn076i-361-2 ( Induced pluripotent stem cell line )

  • Penn077i-521-1 ( Induced pluripotent stem cell line )

  • Penn078i-SV10 ( Induced pluripotent stem cell line )

  • Penn079i-33-1 ( Induced pluripotent stem cell line )

  • Penn080i-603-1 ( Induced pluripotent stem cell line )

  • Penn081i-352-4 ( Induced pluripotent stem cell line )

  • Penn082i-562-6 ( Induced pluripotent stem cell line )

  • Penn083i-679-4 ( Induced pluripotent stem cell line )

  • Penn084i-555-2 ( Induced pluripotent stem cell line )

  • Penn085i-76-5 ( Induced pluripotent stem cell line )

  • Penn086i-278-1 ( Induced pluripotent stem cell line )

  • Penn087i-38-1 ( Induced pluripotent stem cell line )

  • Penn088i-854-7 ( Induced pluripotent stem cell line )

  • Penn089i-758-4 ( Induced pluripotent stem cell line )

  • Penn090i-111-4 ( Induced pluripotent stem cell line )

  • Penn091i-588-2 ( Induced pluripotent stem cell line )

  • Penn092i-560-3 ( Induced pluripotent stem cell line )

  • Penn093i-16-7 ( Induced pluripotent stem cell line )

  • Penn094i-161-1 ( Induced pluripotent stem cell line )

  • Penn095i-123-7 ( Induced pluripotent stem cell line )

  • Penn096i-44-4 ( Induced pluripotent stem cell line )

  • Penn097i-17-1 ( Induced pluripotent stem cell line )

  • Penn098i-50-18 ( Induced pluripotent stem cell line )

  • Penn099i-218-1 ( Induced pluripotent stem cell line )

  • Penn100i-623-3 ( Induced pluripotent stem cell line )

  • Penn101i-263-39 ( Induced pluripotent stem cell line )

  • Penn102i-96-1 ( Induced pluripotent stem cell line )

  • Penn103i-330-4 ( Induced pluripotent stem cell line )

  • Penn104i-321-6 ( Induced pluripotent stem cell line )

  • Penn105i-342-5 ( Induced pluripotent stem cell line )

  • Penn106i-75-39 ( Induced pluripotent stem cell line )

  • Penn107i-145-1 ( Induced pluripotent stem cell line )

  • Penn108i-781-3 ( Induced pluripotent stem cell line )

  • Penn109i-802-2 ( Induced pluripotent stem cell line )

  • Penn110i-389-6 ( Induced pluripotent stem cell line )

  • Penn111i-222-5 ( Induced pluripotent stem cell line )

  • Penn112i-304-6 ( Induced pluripotent stem cell line )

  • Penn113i-126-66 ( Induced pluripotent stem cell line )

  • Penn114i-127-2 ( Induced pluripotent stem cell line )

  • Penn115i-316-1 ( Induced pluripotent stem cell line )

  • Penn116i-125-16 ( Induced pluripotent stem cell line )

  • Penn117i-88-32 ( Induced pluripotent stem cell line )

  • Penn118i-113-2 ( Induced pluripotent stem cell line )

  • Penn119i-197-25 ( Induced pluripotent stem cell line )

  • Penn120i-444-1 ( Induced pluripotent stem cell line )

  • Penn121i-69-1 ( Induced pluripotent stem cell line )

  • Penn122i-627-5 ( Induced pluripotent stem cell line )

  • Penn123i-SV20 ( Induced pluripotent stem cell line )

  • Penn124i-28-3 ( Induced pluripotent stem cell line )

  • Penn125i-233-4 ( Induced pluripotent stem cell line )

  • Penn126i-120-1 ( Induced pluripotent stem cell line )

  • Penn127i-415-1 ( Induced pluripotent stem cell line )

  • Penn128i-8-4 ( Induced pluripotent stem cell line )

  • Penn129i-20-14 ( Induced pluripotent stem cell line )

  • Penn130i-78-3 ( Induced pluripotent stem cell line )

  • Penn131i-86-3 ( Induced pluripotent stem cell line )

  • Penn132i-131-5 ( Induced pluripotent stem cell line )

  • Penn133i-252-23 ( Induced pluripotent stem cell line )

  • Penn134i-61-26 ( Induced pluripotent stem cell line )

  • Penn135i-30-8 ( Induced pluripotent stem cell line )

  • Penn136i-262-1 ( Induced pluripotent stem cell line )

  • Penn137i-18-11 ( Induced pluripotent stem cell line )

  • Penn138i-24-4 ( Induced pluripotent stem cell line )

  • Penn139i-M5-4 ( Induced pluripotent stem cell line )

  • Penn140i-M12-7 ( Induced pluripotent stem cell line )

  • Penn141i-M6-2 ( Induced pluripotent stem cell line )

  • Penn142i-M3-19 ( Induced pluripotent stem cell line )

  • Penn143i-M10-11 ( Induced pluripotent stem cell line )

  • Penn144i-M7-16 ( Induced pluripotent stem cell line )

  • Penn145i-M16-2 ( Induced pluripotent stem cell line )

  • Penn146i-M11-5 ( Induced pluripotent stem cell line )

  • Penn147i-M9-7 ( Induced pluripotent stem cell line )

  • Penn148i-M8-3 ( Induced pluripotent stem cell line )

  • Penn149i-M1-6 ( Induced pluripotent stem cell line )

  • Penn150i-M7-9 ( Induced pluripotent stem cell line )

  • Penn151i-M1-5 ( Induced pluripotent stem cell line )

  • Penn152i-M18-1 ( Induced pluripotent stem cell line )

  • Penn153i-M4-10 ( Induced pluripotent stem cell line )

  • Penn154i-M18-2 ( Induced pluripotent stem cell line )

  • Penn155i-M3-21 ( Induced pluripotent stem cell line )

  • Penn156i-M8-2 ( Induced pluripotent stem cell line )

  • Penn157i-M2-6 ( Induced pluripotent stem cell line )

  • Penn158i-M12-4 ( Induced pluripotent stem cell line )

  • Penn159i-M14-4 ( Induced pluripotent stem cell line )

  • Penn160i-M6-6 ( Induced pluripotent stem cell line )

  • Penn161i-M10-5 ( Induced pluripotent stem cell line )

  • Penn162i-M14-11 ( Induced pluripotent stem cell line )

  • Penn163i-M4-4 ( Induced pluripotent stem cell line )

  • Penn164i-M11-1 ( Induced pluripotent stem cell line )

  • Penn165i-M2-21 ( Induced pluripotent stem cell line )

  • Penn166i-M15-4 ( Induced pluripotent stem cell line )

  • Penn167i-M5-3 ( Induced pluripotent stem cell line )

  • Penn168i-M16-1 ( Induced pluripotent stem cell line )

  • Penn169i-M17-3 ( Induced pluripotent stem cell line )

  • Penn170i-M17-4 ( Induced pluripotent stem cell line )

  • Penn171i-M9-9 ( Induced pluripotent stem cell line )

  • Penn172i-M15-10 ( Induced pluripotent stem cell line )

  • SCRP0104i ( Induced pluripotent stem cell line )

    Three sites within the 9p21 region were genotyped for each donor. This donor was homozygous for the risk alleles at all 3 sites (R/R).

  • SCRP0202i ( Induced pluripotent stem cell line )

    Three sites within the 9p21 region were genotyped for each donor. This donor was heterozygous for the risk and non-risk alleles at all 3 sites (R/NR).

  • SCRP0203i ( Induced pluripotent stem cell line )

    Three sites within the 9p21 region were genotyped for each donor. This donor was homozygous for the non-risk alleles at all 3 sites (NR/NR).

  • SCRP0302i ( Induced pluripotent stem cell line )

    Three sites within the 9p21 region were genotyped for each donor. This donor was homozygous for the risk alleles at all 3 sites (R/R).

  • SCRP0307i ( Induced pluripotent stem cell line )

    Three sites within the 9p21 region were genotyped for each donor. This donor was homozygous for the non-risk alleles at all 3 sites (NR/NR).

  • SCRP0402i ( Induced pluripotent stem cell line )

    Three sites within the 9p21 region were genotyped for each donor. This donor was heterozygous for the risk and non-risk alleles at all 3 sites (R/NR).

  • SCRP0404i ( Induced pluripotent stem cell line )

    Three sites within the 9p21 region were genotyped for each donor. This donor was homozygous for the risk alleles at all 3 sites (R/R).

  • SCRP0517i ( Induced pluripotent stem cell line )

    Three sites within the 9p21 region were genotyped for each donor. This donor was homozygous for the risk alleles at all 3 sites (R/R).

  • SCRP0601i ( Induced pluripotent stem cell line )

    Three sites within the 9p21 region were genotyped for each donor. This donor was homozygous for the risk alleles at all 3 sites (R/R).

  • SCRP0608i ( Induced pluripotent stem cell line )

    Three sites within the 9p21 region were genotyped for each donor. This donor was heterozygous for the risk and non-risk alleles at all 3 sites (R/NR).

  • SCRP0709i ( Induced pluripotent stem cell line )

    Three sites within the 9p21 region were genotyped for each donor. This donor was homozygous for the non-risk alleles at all 3 sites (NR/NR).

  • SCRP0802i ( Induced pluripotent stem cell line )

    Three sites within the 9p21 region were genotyped for each donor. This donor was homozygous for the non-risk alleles at all 3 sites (NR/NR).

  • SCRP1002i ( Induced pluripotent stem cell line )

    Three sites within the 9p21 region were genotyped for each donor. This donor was homozygous for the non-risk alleles at all 3 sites (NR/NR).

  • SCRP1005i ( Induced pluripotent stem cell line )

  • SCRP1021i ( Induced pluripotent stem cell line )

    Three sites within the 9p21 region were genotyped for each donor. This donor was homozygous for the risk alleles at all 3 sites (R/R).

  • SCRP1031i ( Induced pluripotent stem cell line )

    Three sites within the 9p21 region were genotyped for each donor. This donor was homozygous for the risk alleles at all 3 sites (R/R).

  • SCRP1041i ( Induced pluripotent stem cell line )

    Three sites within the 9p21 region were genotyped for each donor. This donor was homozygous for the non-risk alleles at all 3 sites (NR/NR).

  • SCRP1103i ( Induced pluripotent stem cell line )

    Three sites within the 9p21 region were genotyped for each donor. This donor was homozygous for the risk alleles at all 3 sites (R/R).

  • SCRP1203i ( Induced pluripotent stem cell line )

    Three sites within the 9p21 region were genotyped for each donor. This donor was homozygous for the non-risk alleles at all 3 sites (NR/NR).

  • SCRP1307i ( Induced pluripotent stem cell line )

    Three sites within the 9p21 region were genotyped for each donor. This donor was heterozygous for the risk and non-risk alleles at all 3 sites (R/NR).

  • SCRP1602i ( Induced pluripotent stem cell line )

    Three sites within the 9p21 region were genotyped for each donor. This donor was heterozygous for the risk and non-risk alleles at all 3 sites (R/NR).

  • SCRP1702i ( Induced pluripotent stem cell line )

    Three sites within the 9p21 region were genotyped for each donor. This donor was heterozygous for the risk and non-risk alleles at all 3 sites (R/NR).

  • SCRP2001i ( Induced pluripotent stem cell line )

    Three sites within the 9p21 region were genotyped for each donor. This donor was homozygous for the non-risk alleles at all 3 sites (NR/NR).

  • SCRP2101i ( Induced pluripotent stem cell line )

    Three sites within the 9p21 region were genotyped for each donor. This donor was heterozygous for the risk and non-risk alleles at all 3 sites (R/NR).

  • SCRP2102i ( Induced pluripotent stem cell line )

    Three sites within the 9p21 region were genotyped for each donor. This donor was homozygous for the risk alleles at all 3 sites (R/R).

  • SCRP2106i ( Induced pluripotent stem cell line )

    Three sites within the 9p21 region were genotyped for each donor. This donor was heterozygous for the risk and non-risk alleles at all 3 sites (R/NR).

  • SCRP2115i ( Induced pluripotent stem cell line )

    Three sites within the 9p21 region were genotyped for each donor. This donor was heterozygous for the risk and non-risk alleles at all 3 sites (R/NR).

  • SCRP2201i ( Induced pluripotent stem cell line )

    Three sites within the 9p21 region were genotyped for each donor. This donor was heterozygous for the risk and non-risk alleles at all 3 sites (R/NR).

  • SCRP2208i ( Induced pluripotent stem cell line )

    Three sites within the 9p21 region were genotyped for each donor. This donor was heterozygous for the risk and non-risk alleles at all 3 sites (R/NR).

  • SCRP2210i ( Induced pluripotent stem cell line )

    Three sites within the 9p21 region were genotyped for each donor. This donor was heterozygous for the risk and non-risk alleles at all 3 sites (R/NR).

  • SCRP2211i ( Induced pluripotent stem cell line )

    Three sites within the 9p21 region were genotyped for each donor. This donor was heterozygous for the risk and non-risk alleles at all 3 sites (R/NR).

  • SCRP2305i ( Induced pluripotent stem cell line )

    Three sites within the 9p21 region were genotyped for each donor. This donor was homozygous for the non-risk alleles at all 3 sites (NR/NR).

  • SCRP2306i ( Induced pluripotent stem cell line )

    Three sites within the 9p21 region were genotyped for each donor. This donor was homozygous for the risk alleles at all 3 sites (R/R).

  • SCRP2307i ( Induced pluripotent stem cell line )

    Three sites within the 9p21 region were genotyped for each donor. This donor was homozygous for the non-risk alleles at all 3 sites (NR/NR).

  • SCRP2310i ( Induced pluripotent stem cell line )

    Three sites within the 9p21 region were genotyped for each donor. This donor was homozygous for the non-risk alleles at all 3 sites (NR/NR).

  • SCRP2407i ( Induced pluripotent stem cell line )

    Three sites within the 9p21 region were genotyped for each donor. This donor was heterozygous for the risk and non-risk alleles at all 3 sites (R/NR).

  • SCRP2409i ( Induced pluripotent stem cell line )

    Three sites within the 9p21 region were genotyped for each donor. This donor was heterozygous for the risk and non-risk alleles at all 3 sites (R/NR).

  • SCRP2411i ( Induced pluripotent stem cell line )

    Three sites within the 9p21 region were genotyped for each donor. This donor was heterozygous for the risk and non-risk alleles at all 3 sites (R/NR).

  • SCRP2501i ( Induced pluripotent stem cell line )

    Three sites within the 9p21 region were genotyped for each donor. This donor was heterozygous for the risk and non-risk alleles at all 3 sites (R/NR).

  • SCRP2503i ( Induced pluripotent stem cell line )

    Three sites within the 9p21 region were genotyped for each donor. This donor was homozygous for the risk alleles at all 3 sites (R/R).

  • SCRP2506i ( Induced pluripotent stem cell line )

    Three sites within the 9p21 region were genotyped for each donor. This donor was homozygous for the risk alleles at all 3 sites (R/R).

  • SCRP2508i ( Induced pluripotent stem cell line )

    Three sites within the 9p21 region were genotyped for each donor. This donor was homozygous for the risk alleles at all 3 sites (R/R).

  • SCRP2706i ( Induced pluripotent stem cell line )

    Three sites within the 9p21 region were genotyped for each donor. This donor was heterozygous for the risk and non-risk alleles at all 3 sites (R/NR).

  • SCRP2801i ( Induced pluripotent stem cell line )

    Three sites within the 9p21 region were genotyped for each donor. This donor was heterozygous for the risk and non-risk alleles at all 3 sites (R/NR).

  • SCRP3202i ( Induced pluripotent stem cell line )

    Three sites within the 9p21 region were genotyped for each donor. This donor was homozygous for the risk alleles at all 3 sites (R/R).

  • SCRP3304i ( Induced pluripotent stem cell line )

    Three sites within the 9p21 region were genotyped for each donor. This donor was heterozygous for the risk and non-risk alleles at all 3 sites (R/NR).

  • SCRP3401i ( Induced pluripotent stem cell line )

    Three sites within the 9p21 region were genotyped for each donor. This donor was heterozygous for the risk and non-risk alleles at all 3 sites (R/NR).

  • SCRP3510i ( Induced pluripotent stem cell line )

    Three sites within the 9p21 region were genotyped for each donor. This donor was homozygous for the non-risk alleles at all 3 sites (NR/NR).

  • SCRP3601i ( Induced pluripotent stem cell line )

    Three sites within the 9p21 region were genotyped for each donor. This donor was homozygous for the risk alleles at all 3 sites (R/R).

  • SCRP3702i ( Induced pluripotent stem cell line )

    Three sites within the 9p21 region were genotyped for each donor. This donor was homozygous for the risk alleles at all 3 sites (R/R).

  • SCRP3803i ( Induced pluripotent stem cell line )

    Three sites within the 9p21 region were genotyped for each donor. This donor was homozygous for the non-risk alleles at all 3 sites (NR/NR).

  • SCRP3901i ( Induced pluripotent stem cell line )

    Three sites within the 9p21 region were genotyped for each donor. This donor was heterozygous for the risk and non-risk alleles at all 3 sites (R/NR).

  • SCRP4102i ( Induced pluripotent stem cell line )

    Three sites within the 9p21 region were genotyped for each donor. This donor was homozygous for the risk alleles at all 3 sites (R/R).

  • SCRP4201i ( Induced pluripotent stem cell line )

    Three sites within the 9p21 region were genotyped for each donor. This donor was heterozygous for the risk and non-risk alleles at all 3 sites (R/NR).

  • SCRP4203i ( Induced pluripotent stem cell line )

    Three sites within the 9p21 region were genotyped for each donor. This donor had a mix of genotypes at the 3 sites.

  • SCRP4301i ( Induced pluripotent stem cell line )

    Three sites within the 9p21 region were genotyped for each donor. This donor was homozygous for the non-risk alleles at all 3 sites (NR/NR).

  • SCRP4305i ( Induced pluripotent stem cell line )

    Three sites within the 9p21 region were genotyped for each donor. This donor was heterozygous for the risk and non-risk alleles at all 3 sites (R/NR).

  • SCRP4403i ( Induced pluripotent stem cell line )

    Three sites within the 9p21 region were genotyped for each donor. This donor was heterozygous for the risk and non-risk alleles at all 3 sites (R/NR).

  • SCRP4406i ( Induced pluripotent stem cell line )

    Three sites within the 9p21 region were genotyped for each donor. This donor was heterozygous for the risk and non-risk alleles at all 3 sites (R/NR).

  • SCRP4502i ( Induced pluripotent stem cell line )

    Three sites within the 9p21 region were genotyped for each donor. This donor was heterozygous for the risk and non-risk alleles at all 3 sites (R/NR).

  • SCRP4505i ( Induced pluripotent stem cell line )

    Three sites within the 9p21 region were genotyped for each donor. This donor was homozygous for the non-risk alleles at all 3 sites (NR/NR).

  • SCRP4602i ( Induced pluripotent stem cell line )

    Three sites within the 9p21 region were genotyped for each donor. This donor was homozygous for the risk alleles at all 3 sites (R/R).

  • SCRP4603i ( Induced pluripotent stem cell line )

    Three sites within the 9p21 region were genotyped for each donor. This donor was heterozygous for the risk and non-risk alleles at all 3 sites (R/NR).

  • SCRP4703i ( Induced pluripotent stem cell line )

    Three sites within the 9p21 region were genotyped for each donor. This donor was homozygous for the risk alleles at all 3 sites (R/R).

  • SCRP4803i ( Induced pluripotent stem cell line )

    Three sites within the 9p21 region were genotyped for each donor. This donor was homozygous for the risk alleles at all 3 sites (R/R).

  • SCRP4903i ( Induced pluripotent stem cell line )

    Three sites within the 9p21 region were genotyped for each donor. This donor was heterozygous for the risk and non-risk alleles at all 3 sites (R/NR).

  • SCRP5003i ( Induced pluripotent stem cell line )

    Three sites within the 9p21 region were genotyped for each donor. This donor was homozygous for the non-risk alleles at all 3 sites (NR/NR).

  • SCRP5402i ( Induced pluripotent stem cell line )

    Three sites within the 9p21 region were genotyped for each donor. This donor was homozygous for the risk alleles at all 3 sites (R/R).

  • SCRP5508i ( Induced pluripotent stem cell line )

    Three sites within the 9p21 region were genotyped for each donor. This donor was homozygous for the non-risk alleles at all 3 sites (NR/NR).

  • SCRP5603i ( Induced pluripotent stem cell line )

    Three sites within the 9p21 region were genotyped for each donor. This donor was homozygous for the non-risk alleles at all 3 sites (NR/NR).

  • SCRP5707i ( Induced pluripotent stem cell line )

    Three sites within the 9p21 region were genotyped for each donor. This donor was heterozygous for the risk and non-risk alleles at all 3 sites (R/NR).

  • SCRP5803i ( Induced pluripotent stem cell line )

    Three sites within the 9p21 region were genotyped for each donor. This donor was homozygous for the risk alleles at all 3 sites (R/R).

  • SCRP6007i ( Induced pluripotent stem cell line )

    Three sites within the 9p21 region were genotyped for each donor. This donor was heterozygous for the risk and non-risk alleles at all 3 sites (R/NR).

  • SCRP6101i ( Induced pluripotent stem cell line )

    Three sites within the 9p21 region were genotyped for each donor. This donor was homozygous for the risk alleles at all 3 sites (R/R).

  • SCRP6301i ( Induced pluripotent stem cell line )

    Three sites within the 9p21 region were genotyped for each donor. This donor was homozygous for the non-risk alleles at all 3 sites (NR/NR).

  • SCRP6401i ( Induced pluripotent stem cell line )

    Three sites within the 9p21 region were genotyped for each donor. This donor was homozygous for the risk alleles at all 3 sites (R/R).

  • SCRP6504i ( Induced pluripotent stem cell line )

    Three sites within the 9p21 region were genotyped for each donor. This donor was homozygous for the risk alleles at all 3 sites (R/R).

  • SCRP6703i ( Induced pluripotent stem cell line )

    Three sites within the 9p21 region were genotyped for each donor. This donor was heterozygous for the risk and non-risk alleles at all 3 sites (R/NR).

  • SCRP6904i ( Induced pluripotent stem cell line )

    Three sites within the 9p21 region were genotyped for each donor. This donor was homozygous for the non-risk alleles at all 3 sites (NR/NR).

  • SCRP7301i ( Induced pluripotent stem cell line )

    Three sites within the 9p21 region were genotyped for each donor. This donor was homozygous for the non-risk alleles at all 3 sites (NR/NR).

  • SCRP7602i ( Induced pluripotent stem cell line )

    Three sites within the 9p21 region were genotyped for each donor. This donor was heterozygous for the risk and non-risk alleles at all 3 sites (R/NR).

  • SCRP7803i ( Induced pluripotent stem cell line )

    Three sites within the 9p21 region were genotyped for each donor. This donor was homozygous for the non-risk alleles at all 3 sites (NR/NR).

  • SCRP7903i ( Induced pluripotent stem cell line )

    Three sites within the 9p21 region were genotyped for each donor. This donor was homozygous for the risk alleles at all 3 sites (R/R).

  • SCRP8105i ( Induced pluripotent stem cell line )

    Three sites within the 9p21 region were genotyped for each donor. This donor was homozygous for the non-risk alleles at all 3 sites (NR/NR).

  • SCRP8305i ( Induced pluripotent stem cell line )

    Three sites within the 9p21 region were genotyped for each donor. This donor was homozygous for the risk alleles at all 3 sites (R/R).

  • SCRP8401i ( Induced pluripotent stem cell line )

    Three sites within the 9p21 region were genotyped for each donor. This donor was heterozygous for the risk and non-risk alleles at all 3 sites (R/NR).

  • SCRP8503i ( Induced pluripotent stem cell line )

    Three sites within the 9p21 region were genotyped for each donor. This donor was homozygous for the non-risk alleles at all 3 sites (NR/NR).

  • SCRP8601i ( Induced pluripotent stem cell line )

    Three sites within the 9p21 region were genotyped for each donor. This donor was homozygous for the risk alleles at all 3 sites (R/R).

  • SCRP8717i ( Induced pluripotent stem cell line )

    Three sites within the 9p21 region were genotyped for each donor. This donor was homozygous for the risk alleles at all 3 sites (R/R).

  • SCRP8901i ( Induced pluripotent stem cell line )

    Three sites within the 9p21 region were genotyped for each donor. This donor was heterozygous for the risk and non-risk alleles at all 3 sites (R/NR).

  • SCRP9001i ( Induced pluripotent stem cell line )

    Three sites within the 9p21 region were genotyped for each donor. This donor was homozygous for the non-risk alleles at all 3 sites (NR/NR).

  • SCRP9301i ( Induced pluripotent stem cell line )

    Three sites within the 9p21 region were genotyped for each donor. This donor was homozygous for the non-risk alleles at all 3 sites (NR/NR).

  • SCRP9403i ( Induced pluripotent stem cell line )

    Three sites within the 9p21 region were genotyped for each donor. This donor was homozygous for the non-risk alleles at all 3 sites (NR/NR).

  • SCRP9501i ( Induced pluripotent stem cell line )

    Three sites within the 9p21 region were genotyped for each donor. This donor was heterozygous for the risk and non-risk alleles at all 3 sites (R/NR).

  • SCRP9602i ( Induced pluripotent stem cell line )

    Three sites within the 9p21 region were genotyped for each donor. This donor was heterozygous for the risk and non-risk alleles at all 3 sites (R/NR).

  • SCRP9805i ( Induced pluripotent stem cell line )

    Three sites within the 9p21 region were genotyped for each donor. This donor was heterozygous for the risk and non-risk alleles at all 3 sites (R/NR).

  • SCRP9904i ( Induced pluripotent stem cell line )

    Three sites within the 9p21 region were genotyped for each donor. This donor was heterozygous for the risk and non-risk alleles at all 3 sites (R/NR).

  • STAN001i-047-1 ( Induced pluripotent stem cell line )

    Non-affected Control

  • STAN002i-161-1 ( Induced pluripotent stem cell line )

    Non-affected Control

  • STAN003i-161-2 ( Induced pluripotent stem cell line )

    Non-affected Control

  • STAN004i-147-1 ( Induced pluripotent stem cell line )

    Non-affected Control

  • STAN005i-147-2 ( Induced pluripotent stem cell line )

    Non-affected Control

  • STAN006i-148-1 ( Induced pluripotent stem cell line )

    Non-affected Control

  • STAN007i-148-2 ( Induced pluripotent stem cell line )

    Non-affected Control

  • STAN008i-165-1 ( Induced pluripotent stem cell line )

    Non-affected Control

  • STAN009i-165-2 ( Induced pluripotent stem cell line )

    Non-affected Control

  • STAN010i-041-2 ( Induced pluripotent stem cell line )

    Idiopathic pulmonary arterial hypertension

  • STAN011i-123-1 ( Induced pluripotent stem cell line )

    Drugs and toxins-associated pulmonary arterial hypertension

  • STAN012i-123-2 ( Induced pluripotent stem cell line )

    Drugs and toxins-associated pulmonary arterial hypertension

  • STAN013i-121-1 ( Induced pluripotent stem cell line )

    Idiopathic pulmonary arterial hypertension

  • STAN014i-121-2 ( Induced pluripotent stem cell line )

    Idiopathic pulmonary arterial hypertension

  • STAN015i-178-1 ( Induced pluripotent stem cell line )

    Drugs and toxins-associated pulmonary arterial hypertension

  • STAN016i-178-2 ( Induced pluripotent stem cell line )

    Drugs and toxins-associated pulmonary arterial hypertension

  • STAN017i-171-1 ( Induced pluripotent stem cell line )

    Idiopathic pulmonary arterial hypertension

  • STAN018i-171-2 ( Induced pluripotent stem cell line )

    Idiopathic pulmonary arterial hypertension

  • STAN019i-177-1 ( Induced pluripotent stem cell line )

    Idiopathic pulmonary arterial hypertension

  • STAN020i-177-2 ( Induced pluripotent stem cell line )

    Idiopathic pulmonary arterial hypertension

  • STAN021i-170-1 ( Induced pluripotent stem cell line )

    Non-affected Control

  • STAN022i-170-2 ( Induced pluripotent stem cell line )

    Non-affected Control

  • STAN023i-41-1 ( Induced pluripotent stem cell line )

    Idiopathic Pulmonary Arterial Hypertension

  • STAN024i-29-1 ( Induced pluripotent stem cell line )

    Familial pulmonary arterial hypertension

  • STAN025i-29-2 ( Induced pluripotent stem cell line )

    Familial pulmonary arterial hypertension

  • STAN026i-30-1 ( Induced pluripotent stem cell line )

    Associated Pulmonary Arterial Hypertension with pulmonary veno-occlusive disease

  • STAN027i-30-2 ( Induced pluripotent stem cell line )

    Associated Pulmonary Arterial Hypertension with pulmonary veno-occlusive disease

  • STAN028i-42-1 ( Induced pluripotent stem cell line )

    Idiopathic Pulmonary Arterial Hypertension

  • STAN029i-42-2 ( Induced pluripotent stem cell line )

    Idiopathic Pulmonary Arterial Hypertension

  • STAN030i-46-1 ( Induced pluripotent stem cell line )

    Familial pulmonary arterial hypertension

  • STAN031i-46-2 ( Induced pluripotent stem cell line )

    Familial pulmonary arterial hypertension

  • STAN032i-48-1 ( Induced pluripotent stem cell line )

    Non-affected Control

  • STAN034i-48-2 ( Induced pluripotent stem cell line )

    Non-affected Control

  • STAN035i-49-1 ( Induced pluripotent stem cell line )

    Non-affected Control

  • STAN036i-49-2 ( Induced pluripotent stem cell line )

    Non-affected Control

  • STAN037i-118-1 ( Induced pluripotent stem cell line )

    Associated Pulmonary Arterial Hypertension with ventricular septal defect and Eisenmenger's Syndrome

  • STAN038i-118-2 ( Induced pluripotent stem cell line )

    Associated Pulmonary Arterial Hypertension with ventricular septal defect and Eisenmenger's Syndrome

  • STAN039i-119-1 ( Induced pluripotent stem cell line )

    Associated Pulmonary Arterial Hypertension with Lupus and pulmonary fibrosis

  • STAN040i-119-2 ( Induced pluripotent stem cell line )

    Associated Pulmonary Arterial Hypertension with Lupus and pulmonary fibrosis

  • STAN041i-122-1 ( Induced pluripotent stem cell line )

    Associated Pulmonary Arterial Hypertension with s/pand patent ductus arteriosus

  • STAN042i-122-2 ( Induced pluripotent stem cell line )

    Associated Pulmonary Arterial Hypertension with s/pand patent ductus arteriosus

  • STAN043i-124-1 ( Induced pluripotent stem cell line )

    Associated Pulmonary Arterial Hypertension with ventricular septal defect and Eisenmenger's Syndrome

  • STAN044i-124-2 ( Induced pluripotent stem cell line )

    Associated Pulmonary Arterial Hypertension with ventricular septal defect and Eisenmenger's Syndrome

  • STAN045i-125-1 ( Induced pluripotent stem cell line )

    Associated Pulmonary Arterial Hypertension with Eisenmenger's Syndrome

  • STAN046i-125-2 ( Induced pluripotent stem cell line )

    Associated Pulmonary Arterial Hypertension with Eisenmenger's Syndrome

  • STAN047i-126-1 ( Induced pluripotent stem cell line )

    Non-affected Control

  • STAN048i-126-2 ( Induced pluripotent stem cell line )

    Non-affected Control

  • STAN051i-146-1 ( Induced pluripotent stem cell line )

    Non-affected Control

  • STAN052i-146-2 ( Induced pluripotent stem cell line )

    Non-affected Control

  • STAN053i-149-1 ( Induced pluripotent stem cell line )

    Non-affected Control

  • STAN054i-149-2 ( Induced pluripotent stem cell line )

    Non-affected Control

  • STAN055i-160-1 ( Induced pluripotent stem cell line )

    Non-affected Control

  • STAN056i-160-2 ( Induced pluripotent stem cell line )

    Non-affected Control

  • STAN057i-162-1 ( Induced pluripotent stem cell line )

    Non-affected Control

  • STAN058i-162-2 ( Induced pluripotent stem cell line )

    Non-affected Control

  • STAN059i-163-1 ( Induced pluripotent stem cell line )

    Non-affected Control

  • STAN060i-163-2 ( Induced pluripotent stem cell line )

    Non-affected Control

  • STAN061i-164-1 ( Induced pluripotent stem cell line )

    Non-affected Control

  • STAN062i-164-2 ( Induced pluripotent stem cell line )

    Non-affected Control

  • STAN063i-166-1 ( Induced pluripotent stem cell line )

    Non-affected Control

  • STAN064i-166-2 ( Induced pluripotent stem cell line )

    Non-affected Control

  • STAN065i-167-1 ( Induced pluripotent stem cell line )

    Idiopathic Pulmonary Arterial Hypertension

  • STAN066i-167-2 ( Induced pluripotent stem cell line )

    Idiopathic Pulmonary Arterial Hypertension

  • STAN067i-168-1 ( Induced pluripotent stem cell line )

    Idiopathic Pulmonary Arterial Hypertension

  • STAN068i-168-2 ( Induced pluripotent stem cell line )

    Idiopathic Pulmonary Arterial Hypertension

  • STAN069i-169-1 ( Induced pluripotent stem cell line )

    Drugs and toxins-associated pulmonary arterial hypertension

  • STAN070i-169-2 ( Induced pluripotent stem cell line )

    Drugs and toxins-associated pulmonary arterial hypertension

  • STAN071i-179-1 ( Induced pluripotent stem cell line )

    Familial Pulmonary Arterial Hypertension with Drugs and Toxins-Associated history

  • STAN072i-179-2 ( Induced pluripotent stem cell line )

    Familial Pulmonary Arterial Hypertension with Drugs and Toxins-Associated history

  • STAN073i-180-1 ( Induced pluripotent stem cell line )

    Idiopathic Pulmonary Arterial Hypertension

  • STAN074i-180-2 ( Induced pluripotent stem cell line )

    Idiopathic Pulmonary Arterial Hypertension

  • STAN076i-004C1 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 197
    Group: Insulin Resistant

  • STAN077i-004C2 ( Induced pluripotent stem cell line )

  • STAN077i-004C2 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 197
    Group: Insulin Resistant

  • STAN078i-018C2 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 180
    Group: Intermediate

  • STAN079i-018C3 ( Induced pluripotent stem cell line )

  • STAN079i-018C3 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 180
    Group: Intermediate

  • STAN080i-023C2 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 142
    Group: Intermediate

  • STAN081i-023C3 ( Induced pluripotent stem cell line )

  • STAN081i-023C3 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 142
    Group: Intermediate

  • STAN082i-024C1 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 153
    Group: Intermediate

  • STAN083i-024C4 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 153
    Group: Intermediate

  • STAN084i-041C1 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 108
    Group: Intermediate

  • STAN085i-041C3 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 108
    Group: Intermediate

  • STAN086i-054C1 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 145
    Group: Intermediate

  • STAN087i-054C2 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 145
    Group: Intermediate

  • STAN088i-060C1 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 196
    Group: Insulin Resistant

  • STAN089i-070C2 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 267
    Group: Insulin Resistant

  • STAN090i-070C4 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 267
    Group: Insulin Resistant

  • STAN091i-071C2 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 77
    Group: Insulin Sensitive

  • STAN093i-081C1 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 171
    Group: Intermediate

  • STAN094i-081C2 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 171
    Group: Intermediate

  • STAN095i-102C4 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 136
    Group: Intermediate

  • STAN096i-102C6 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 136
    Group: Intermediate

  • STAN097i-107C3 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 66
    Group: Insulin Sensitive

  • STAN098i-107C4 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 66
    Group: Insulin Sensitive

  • STAN099i-108C2 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 88
    Group: Insulin Sensitive

  • STAN100i-108C4 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 88
    Group: Insulin Sensitive

  • STAN104i-120C3 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 129
    Group: Intermediate

  • STAN106i-121C1 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 233
    Group: Insulin Resistant

  • STAN107i-121C2 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 233
    Group: Insulin Resistant

  • STAN108i-123C2 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 174
    Group: Intermediate

  • STAN109i-123C3 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 174
    Group: Intermediate

  • STAN111i-125C4 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 186
    Group: Intermediate

  • STAN114i-135C2 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 98
    Group: Insulin Sensitive

  • STAN115i-148C2 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 266
    Group: Insulin Resistant

  • STAN116i-148C4 ( Induced pluripotent stem cell line )

  • STAN117i-182C4 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 280
    Group: Insulin Resistant

  • STAN118i-182C7 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 280
    Group: Insulin Resistant

  • STAN119i-192C1 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 103
    Group: Insulin Sensitive

  • STAN120i-192C2 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 103
    Group: Insulin Sensitive

  • STAN121i-193C2 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 255
    Group: Insulin Resistant

  • STAN122i-193C1 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 255
    Group: Insulin Resistant

  • STAN125i-202C2 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 181
    Group: Intermediate

  • STAN126i-202C3 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 181
    Group: Intermediate

  • STAN128i-211C2 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 80
    Group: Insulin Sensitive

  • STAN129i-212C2 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 141
    Group: Intermediate

  • STAN130i-212C4 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 141
    Group: Intermediate

  • STAN131i-214C3 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 53
    Group: Insulin Sensitive

  • STAN132i-214C4 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 53
    Group: Insulin Sensitive

  • STAN133i-215C1 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 91
    Group: Insulin Sensitive

  • STAN134i-215C2 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 91
    Group: Insulin Sensitive

  • STAN135i-230C1 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 95
    Group: Insulin Sensitive

  • STAN136i-230C2 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 95
    Group: Insulin Sensitive

  • STAN137i-231C3 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 245
    Group: Insulin Resistant

  • STAN138i-239C3 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 272
    Group: Insulin Resistant

  • STAN139i-239C5 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 272
    Group: Insulin Resistant

  • STAN140i-243C1 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 209
    Group: Insulin Resistant

  • STAN141i-250C4 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 187
    Group: Intermediate

  • STAN142i-255C1 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 323
    Group: Insulin Resistant

  • STAN144i-285C3 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 147
    Group: Intermediate

  • STAN145i-286C1 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 67
    Group: Insulin Sensitive

  • STAN146i-286C2 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 67
    Group: Insulin Sensitive

  • STAN148i-291C3 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 94
    Group: Insulin Sensitive

  • STAN149i-298C1 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 145
    Group: Intermediate

  • STAN150i-337C1 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 145
    Group: Intermediate

  • STAN151i-303C3 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 163
    Group: Intermediate

  • STAN152i-307C2 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 199
    Group: Insulin Resistant

  • STAN153i-307C3 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 199
    Group: Insulin Resistant

  • STAN154i-312C1 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 85
    Group: Insulin Sensitive

  • STAN155i-313C2 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 114
    Group: Intermediate

  • STAN156i-334C1 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 115
    Group: Intermediate

  • STAN157i-334C2 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 115
    Group: Intermediate

  • STAN158i-336C2 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 243
    Group: Insulin Resistant

  • STAN159i-336C3 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 243
    Group: Insulin Resistant

  • STAN160i-341C4 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 175
    Group: Intermediate

  • STAN161i-341C5 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 175
    Group: Intermediate

  • STAN162i-345C2 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 50
    Group: Insulin Sensitive

  • STAN163i-345C5 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 50
    Group: Insulin Sensitive

  • STAN164i-352C1 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 100
    Group: Insulin Sensitive

  • STAN165i-352C5 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 100
    Group: Insulin Sensitive

  • STAN166i-356C4 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 73
    Group: Insulin Sensitive

  • STAN167i-356C6 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 73
    Group: Insulin Sensitive

  • STAN168i-358C1 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 212
    Group: Insulin Resistant

  • STAN169i-358C4 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 212
    Group: Insulin Resistant

  • STAN170i-364C3 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 54
    Group: Insulin Sensitive

  • STAN171i-364C4 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 54
    Group: Insulin Sensitive

  • STAN173i-368C2 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 217
    Group: Insulin Resistant

  • STAN174i-371C3 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 73
    Group: Insulin Sensitive

  • STAN175i-373C4 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 165
    Group: Intermediate

  • STAN176i-373C6 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 165
    Group: Intermediate

  • STAN179i-400C2 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 133
    Group: Intermediate

  • STAN180i-408C2 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 253
    Group: Insulin Resistant

  • STAN181i-408C4 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 253
    Group: Insulin Resistant

  • STAN182i-410C3 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 61
    Group: Insulin Sensitive

  • STAN183i-410C4 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 61
    Group: Insulin Sensitive

  • STAN187i-420C6 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 67
    Group: Insulin Sensitive

  • STAN190i-424C2 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 236
    Group: Insulin Resistant

  • STAN191i-429C2 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 130
    Group: Intermediate

  • STAN192i-429C3 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 130
    Group: Intermediate

  • STAN193i-432C1 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 157
    Group: Intermediate

  • STAN194i-432C3 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 157
    Group: Intermediate

  • STAN195i-434C3 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 200
    Group: Insulin Resistant

  • STAN197i-411C1 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 63
    Group: Insulin Sensitive

  • STAN198i-441C2 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 63
    Group: Insulin Sensitive

  • STAN200i-444C1 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 202
    Group: Insulin Resistant

  • STAN201i-444C2 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 202
    Group: Insulin Resistant

  • STAN202i-445C1 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 104
    Group: Insulin Sensitive

  • STAN203i-445C2 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 104
    Group: Insulin Sensitive

  • STAN204i-448C1 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 145
    Group: Intermediate

  • STAN205i-448C2 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 145
    Group: Intermediate

  • STAN206i-459C1 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 93
    Group: Insulin Sensitive

  • STAN207i-459C2 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 93
    Group: Insulin Sensitive

  • STAN208i-460C2 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 163
    Group: Intermediate

  • STAN209i-460C6 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 163
    Group: Intermediate

  • STAN210i-468C1 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 138
    Group: Intermediate

  • STAN211i-475C1 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 69
    Group: Insulin Sensitive

  • STAN212i-488C2 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 120
    Group: Intermediate

  • STAN213i-488C3 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 120
    Group: Intermediate

  • STAN216i-496C1 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 199
    Group: Insulin Resistant

  • STAN217i-496C2 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 199
    Group: Insulin Resistant

  • STAN218i-501C5 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 142
    Group: Intermediate

  • STAN219i-501C6 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 142
    Group: Intermediate

  • STAN220i-504C2 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 92
    Group: Insulin Sensitive

  • STAN222i-509C2 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 69
    Group: Insulin Sensitive

  • STAN223i-509C3 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 69
    Group: Insulin Sensitive

  • STAN224i-514C3 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 173
    Group: Intermediate

  • STAN225i-514C4 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 173
    Group: Intermediate

  • STAN226i-516C3 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 57
    Group: Insulin Sensitive

  • STAN227i-516C5 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 57
    Group: Insulin Sensitive

  • STAN228i-523C1 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 215
    Group: Insulin Resistant

  • STAN229i-523C2 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 215
    Group: Insulin Resistant

  • STAN230i-533C1 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 193
    Group: Insulin Resistant

  • STAN231i-533C2 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 193
    Group: Insulin Resistant

  • STAN232i-541C2 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 60
    Group: Insulin Sensitive

  • STAN233i-541C5 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 60
    Group: Insulin Sensitive

  • STAN234i-546C1 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 202
    Group: Insulin Resistant

  • STAN235i-546C2 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 202
    Group: Insulin Resistant

  • STAN236i-551C1 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 282
    Group: Insulin Resistant

  • STAN237i-551C2 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 282
    Group: Insulin Resistant

  • STAN238i-553C5 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 48
    Group: Insulin Sensitive

  • STAN239i-553C8 ( Induced pluripotent stem cell line )

  • STAN239i-553C8 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 48
    Group: Insulin Sensitive

  • STAN240i-558C3 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 171
    Group: Intermediate

  • STAN241i-558C4 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 171
    Group: Intermediate

  • STAN242i-573C2 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 257
    Group: Insulin Resistant

  • STAN243i-589C3 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 260
    Group: Insulin Resistant

  • STAN244i-589C4 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 260
    Group: Insulin Resistant

  • STAN245i-601C4 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 161
    Group: Intermediate

  • STAN246i-601C5 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 161
    Group: Intermediate

  • STAN247i-614C2 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 117
    Group: Intermediate

  • STAN248i-617C1 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 105
    Group: Insulin Sensitive

  • STAN249i-617C2 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 105
    Group: Insulin Sensitive

  • STAN250i-622C2 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 175
    Group: Intermediate

  • STAN251-637C1 ( Induced pluripotent stem cell line )

  • STAN251i-637C1 ( Induced pluripotent stem cell line )

  • STAN252i-637C2 ( Induced pluripotent stem cell line )

  • STAN252i-637C2 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 168
    Group: Intermediate

  • STAN253i-647C1 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 235
    Group: Insulin Resistant

  • STAN254i-647C3 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 235
    Group: Insulin Resistant

  • STAN255i-649C1 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 106
    Group: Insulin Sensitive

  • STAN256i-649C2 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 106
    Group: Insulin Sensitive

  • STAN257i-685C3 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 132
    Group: Intermediate

  • STAN258i-685C4 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 132
    Group: Intermediate

  • STAN259i-688C1 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 279
    Group: Insulin Resistant

  • STAN260i-688C3 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 279
    Group: Insulin Resistant

  • STAN261i-698C5 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 66
    Group: Insulin Sensitive

  • STAN263i-703C1 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 231
    Group: Insulin Resistant

  • STAN264i-703C2 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 231
    Group: Insulin Resistant

  • STAN265i-707C1 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 76
    Group: Insulin Sensitive

  • STAN266i-707C4 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 76
    Group: Insulin Sensitive

  • STAN269i-720C2 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 49
    Group: Insulin Sensitive

  • STAN270i-720C3 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 49
    Group: Insulin Sensitive

  • STAN271i-726C3 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 251
    Group: Insulin Resistant

  • STAN272i-726C4 ( Induced pluripotent stem cell line )

  • STAN272i-726C4 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 251
    Group: Insulin Resistant

  • STAN273i-729C1 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 244
    Group: Insulin Resistant

  • STAN274i-729C2 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 244
    Group: Insulin Resistant

  • STAN275i-732C1 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 248
    Group: Insulin Resistant

  • STAN276i-756C4 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 60
    Group: Insulin Sensitive

  • STAN277i-756C5 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 60
    Group: Insulin Sensitive

  • STAN278i-767C2 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 178
    Group: Intermediate

  • STAN279i-767C3 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 178
    Group: Intermediate

  • STAN280i-770C1 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 138
    Group: Intermediate

  • STAN281i-770C2 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 138
    Group: Intermediate

  • STAN282i-771C3 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 173
    Group: Intermediate

  • STAN283i-771C4 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 173
    Group: Intermediate

  • STAN284i-780C1 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 82
    Group: Insulin Sensitive

  • STAN285i-780C2 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 82
    Group: Insulin Sensitive

  • STAN286i-799C2 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 89
    Group: Insulin Sensitive

  • STAN287i-810C1 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 106
    Group: Insulin Sensitive

  • STAN288i-810C3 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 106
    Group: Insulin Sensitive

  • STAN291i-827C1 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 181
    Group: Intermediate

  • STAN292i-827C2 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 181
    Group: Intermediate

  • STAN293i-835C1 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 70
    Group: Insulin Sensitive

  • STAN294i-835C5 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 70
    Group: Insulin Sensitive

  • STAN295i-836C1 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 81
    Group: Insulin Sensitive

  • STAN296i-836C2 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 81
    Group: Insulin Sensitive

  • STAN297i-839C1 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 200
    Group: Insulin Resistant

  • STAN298i-839C5 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 200
    Group: Insulin Resistant

  • STAN299i-843C5 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 153
    Group: Intermediate

  • STAN300i-843C6 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 153
    Group: Intermediate

  • STAN301i-845AC2 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 76
    Group: Insulin Sensitive

  • STAN302i-845AC4 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 76
    Group: Insulin Sensitive

  • STAN303i-864C2 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 43
    Group: Insulin Sensitive

  • STAN304i-864C5 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 43
    Group: Insulin Sensitive

  • STAN305i-865C2 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 235
    Group: Insulin Resistant

  • STAN306i-865C3 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 235
    Group: Insulin Resistant

  • STAN307i-871C2 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 202
    Group: Insulin Resistant

  • STAN308i-871C3 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 202
    Group: Insulin Resistant

  • STAN311i-906C1 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 136
    Group: Intermediate

  • STAN312i-906C3 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 136
    Group: Intermediate

  • STAN313i-907C1 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 103
    Group: Insulin Sensitive

  • STAN314i-907C4 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 103
    Group: Insulin Sensitive

  • STAN315i-909C1 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 75
    Group: Insulin Sensitive

  • STAN316i-909C2 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 75
    Group: Insulin Sensitive

  • STAN317i-910C2 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 90
    Group: Insulin Sensitive

  • STAN318i-910C3 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 90
    Group: Insulin Sensitive

  • STAN319i-922C1 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 207
    Group: Insulin Resistant

  • STAN321i-924C1 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 172
    Group: Intermediate

  • STAN322i-924C2 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 172
    Group: Intermediate

  • STAN323i-928C2 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 201
    Group: Insulin Resistant

  • STAN324i-928C6 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 201
    Group: Insulin Resistant

  • STAN327i-940C2 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 103
    Group: Insulin Sensitive

  • STAN328i-946C2 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 212
    Group: Insulin Resistant

  • STAN329i-949C3 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 208
    Group: Insulin Resistant

  • STAN330i-949C4 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 208
    Group: Insulin Resistant

  • STAN331i-952C3 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 82
    Group: Insulin Sensitive

  • STAN332i-952C5 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 82
    Group: Insulin Sensitive

  • STAN333i-955C1 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 82
    Group: Insulin Sensitive

  • STAN334i-955C2 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 82
    Group: Insulin Sensitive

  • STAN336i-963C1 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 258
    Group: Insulin Resistant

  • STAN337i-963C3 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 258
    Group: Insulin Resistant

  • STAN338i-975C1 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 84
    Group: Insulin Sensitive

  • STAN339i-975C3 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 84
    Group: Insulin Sensitive

  • STAN340i-981C1 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 112
    Group: Intermediate

  • STAN341i-994C1 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 102
    Group: Insulin Sensitive

  • STAN342i-994C3 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 102
    Group: Insulin Sensitive

  • STAN343i-998C1 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 102
    Group: Insulin Sensitive

  • STAN345i-390C3 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 102
    Group: Insulin Sensitive

  • STAN346i-59C2 ( Induced pluripotent stem cell line )

  • STAN347i-66C3 ( Induced pluripotent stem cell line )

  • STAN348i-851C1 ( Induced pluripotent stem cell line )

  • STAN349i-762C3 ( Induced pluripotent stem cell line )

  • STAN350i-694C5 ( Induced pluripotent stem cell line )

    Steady-State Plasma Glucose Levels: 90
    Group: Insulin Sensitive

  • STAN351i-631C1 ( Induced pluripotent stem cell line )

  • STAN357i-298C2 ( Induced pluripotent stem cell line )

  • STAN358i-298C3 ( Induced pluripotent stem cell line )

  • STAN359i-442C11 ( Induced pluripotent stem cell line )

  • STAN360i-465C2 ( Induced pluripotent stem cell line )

  • STAN361i-531C6 ( Induced pluripotent stem cell line )

  • STAN362i-178C1 ( Induced pluripotent stem cell line )

  • STAN363i-845C5 ( Induced pluripotent stem cell line )

  • STAN363i-845C5 ( Induced pluripotent stem cell line )

  • STAN364i-055C2 ( Induced pluripotent stem cell line )

  • STAN365i-664C1 ( Induced pluripotent stem cell line )

  • STAN366i-282C2 ( Induced pluripotent stem cell line )

  • STAN367i-894C1 ( Induced pluripotent stem cell line )

  • STAN368i-894C2 ( Induced pluripotent stem cell line )

  • STAN369i-088C3 ( Induced pluripotent stem cell line )

  • STAN370i-190C3 ( Induced pluripotent stem cell line )

  • STAN371i-868C5 ( Induced pluripotent stem cell line )

  • STAN372i-411C8 ( Induced pluripotent stem cell line )

  • STAN373i-412C4 ( Induced pluripotent stem cell line )

  • STAN374i-565C4 ( Induced pluripotent stem cell line )

  • STAN375i-961C1 ( Induced pluripotent stem cell line )

  • STAN376i-518C2 ( Induced pluripotent stem cell line )

  • STAN377i-572C5 ( Induced pluripotent stem cell line )

  • STAN378i-886C4 ( Induced pluripotent stem cell line )

  • STAN379i-783C6 ( Induced pluripotent stem cell line )

  • STAN380i-092C2 ( Induced pluripotent stem cell line )

  • STAN381i-652C1 ( Induced pluripotent stem cell line )

  • UCSD001i-5-1 ( Induced pluripotent stem cell line )

    Cardiomyopathy (Hypertrophic)
    dbGaP iPSC UUID: d6426eb1d8c74352b0d18785820f0ebb

  • UCSD002i-16-1 ( Induced pluripotent stem cell line )

    dbGaP iPSC UUID: e7a035161a5a4739a57db0570e5f898d

  • UCSD003i-16-2 ( Induced pluripotent stem cell line )

    Danon disease, Hypothyroidism
    dbGaP iPSC UUID: e5bc2cdb6047428887860ba08df7dc89

  • UCSD004i-42-1 ( Induced pluripotent stem cell line )

    Left ventricular non-compaction
    dbGaP iPSC UUID: b5f1659be2db4333bc3fc4e85b406d60

  • UCSD005i-43-1 ( Induced pluripotent stem cell line )

    Left ventricular non-compaction
    dbGaP iPSC UUID: a1dc93319ed24d8e98a44aa57e92c67f

  • UCSD006i-21-1 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: 01351a7147854b52b27017ee3a000af0

  • UCSD007i-21-2 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: 7673a09dcd1541938439d9747d306b97

  • UCSD008i-44-1 ( Induced pluripotent stem cell line )

    Left ventricular non-compaction
    dbGaP iPSC UUID: d4ed4dabca7f40e69bcfefb10aa5e912

  • UCSD009i-5-2 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: e14c40862e9c4149bfe175b61ed1cf03

  • UCSD010i-5-3 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: 58a1c8539d524c7dbc03d0886c169483

  • UCSD011i-5-4 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: 7d57a77bf2064bd5b1be5e0e6c635406

  • UCSD012i-5-5 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: fa63c8f9fc7f4892a94cc249617b55f0

  • UCSD013i-16-3 ( Induced pluripotent stem cell line )

    Danon disease
    dbGaP iPSC UUID: 3889851ed91b42d493286defbb16b019

  • UCSD014i-21-3 ( Induced pluripotent stem cell line )

    Cardiomyopathy (dilated)
    dbGaP iPSC UUID: 328b3d3b3e354a1492c169337f04d53f

  • UCSD015i-3-3 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: 9776da372e28418cbf7f63448155e613

  • UCSD016i-3-4 ( Induced pluripotent stem cell line )

    Premature ventricular contractions
    dbGaP iPSC UUID: 9e2eac0aed8a43b796c7dce3e57d62b2

  • UCSD017i-3-5 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: 7f05bb5295c84e5da2010b67b797bd76

  • UCSD018i-3-6 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: dfe586bd8c2440de825c3cc619054169

  • UCSD019i-3-7 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: 6ca9f47754e14ce6b7d31a0e0eb55466

  • UCSD020i-3-8 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: be09429383a945f1b86b14cec0753c4b

  • UCSD021i-3-9 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: 3e2934b33fbf4639968fc6abbc8ec6a1

  • UCSD022i-8-3 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: 68ad20ddc3174da59ec8dea00e7f3eee

  • UCSD023i-8-4 ( Induced pluripotent stem cell line )

    Bells Palsy
    dbGaP iPSC UUID: d903693d3be54763a405850596484ec6

  • UCSD024i-13-3 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: 44a4feabf4ac42db8c6e2d0c5f7561b0

  • UCSD025i-13-4 ( Induced pluripotent stem cell line )

    Neuropathy
    dbGaP iPSC UUID: 148515761a2d402cb40128558480089b

  • UCSD026i-9-1 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: bbe62d3176264700b68b7c7438f6fc18

  • UCSD027i-9-2 ( Induced pluripotent stem cell line )

    Brain tumor
    dbGaP iPSC UUID: c93aac18977f4a50b711cf5dfe35873c

  • UCSD028i-9-3 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: 95b18c63c6e844cfa5ae7f519e4d0855

  • UCSD029i-9-4 ( Induced pluripotent stem cell line )

    Breast cancer
    dbGaP iPSC UUID: 7d5ba701a6074f509bedb8c97ae373c5

  • UCSD030i-23-2 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: e94de898266446b3b52b27f09cb8969b

  • UCSD031i-45-1 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: e45109ae7a2a47a8b7988c86d90f9383

  • UCSD032i-41-1 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: dea2aebd7fde43c9b6e63d1ac635c6f4

  • UCSD033i-41-2 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: 7eeec928a19a4034bdfc5da8e17e8b8d

  • UCSD034i-4-3 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: c4f3f0f065af4647b66a92cd6ed507ca

  • UCSD035i-4-4 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: e468ececa9194e898b54f38b5d79bbab

  • UCSD036i-4-5 ( Induced pluripotent stem cell line )

    High cholesterol, Gout
    dbGaP iPSC UUID: 38d53c6d29f0402fbc2d32adc0bbf220

  • UCSD037i-26-2 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: c993620c6c5746748a84da2432086a23

  • UCSD038i-24-2 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: bb857106e013483baa8ef0cd9d3243e6

  • UCSD039i-14-3 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: 10904b64061a415695b5bf9903398f29

  • UCSD040i-33-1 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: d62a71f74bb249209e96b6fb5df40214

  • UCSD041i-33-2 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: c7c08c01eb7c4b5d88fd34ab6023057d

  • UCSD042i-46-1 ( Induced pluripotent stem cell line )

    Ventricular tachycardia, Atrial septal defect
    dbGaP iPSC UUID: a8165ba0e5454e93bddd0c0e47064d4a

  • UCSD043i-47-1 ( Induced pluripotent stem cell line )

    Atrial Fibrillation
    dbGaP iPSC UUID: 0fbd9cb4095d4e4ea072f4a287431c06

  • UCSD044i-48-1 ( Induced pluripotent stem cell line )

    Long QT Syndrome, Atrial fibrillation
    dbGaP iPSC UUID: 01df4176628b472caafe8cb4878e288f

  • UCSD045i-49-1 ( Induced pluripotent stem cell line )

    Atrial fibrillation
    dbGaP iPSC UUID: 1cc59384fabf4fbca9060c4c5ccba1b5

  • UCSD046i-50-1 ( Induced pluripotent stem cell line )

    Atrial fibrillation
    dbGaP iPSC UUID: 9de465da1c46484c9e7e84ca6ac98dc1

  • UCSD047i-51-1 ( Induced pluripotent stem cell line )

    Atrial fibrillation, Ventricular tachycardia
    dbGaP iPSC UUID: cd73447a59734d0aa91c4d183ab66854

  • UCSD048i-52-1 ( Induced pluripotent stem cell line )

    Coronary artery disease, Atrial fibrillation, Prolonged QT on sotalol
    dbGaP iPSC UUID: 834c008b3d6e484096f1972807855410

  • UCSD049i-53-1 ( Induced pluripotent stem cell line )

    Atrial Fibrillation
    dbGaP iPSC UUID: 51af0c595d9a4553a4aa878cc64f073e

  • UCSD050i-54-1 ( Induced pluripotent stem cell line )

    Atrial Fibrillation
    dbGaP iPSC UUID: 50f5f053b622453e8ff6ebb785d34595

  • UCSD051i-55-1 ( Induced pluripotent stem cell line )

    Atrial Fibrillation
    dbGaP iPSC UUID: a54e68d92da84e1c80d1f06be1f63fad

  • UCSD052i-56-1 ( Induced pluripotent stem cell line )

    Atrial Fibrillation
    dbGaP iPSC UUID: 47326954aed343859c2eb80ce3ac226f

  • UCSD053i-57-1 ( Induced pluripotent stem cell line )

    Atrial Fibrillation
    dbGaP iPSC UUID: 8c5b533be72a449295780e27f341a50f

  • UCSD054i-58-1 ( Induced pluripotent stem cell line )

    Atrial Fibrillation
    dbGaP iPSC UUID: 17c2b6b5c6a544fbb2647cd23c254534

  • UCSD055i-59-1 ( Induced pluripotent stem cell line )

    Cardiomyopathy (Doxorubicin-induced), Thalassemia trait, Breast cancer
    dbGaP iPSC UUID: 7ebf3d3518e2460f8cc67b1cbbafa658

  • UCSD056i-60-1 ( Induced pluripotent stem cell line )

    Cardiomyopathy, ventricular tachycardia, NIDDM
    dbGaP iPSC UUID: 0484f83ba79a4390b6a443f62771e18f

  • UCSD057i-61-1 ( Induced pluripotent stem cell line )

    Atrial Fibrillation, Type II Diabetes, Squamous cell cancer
    dbGaP iPSC UUID: ea17fe9b69da45019c7e6af7aac1b111

  • UCSD058i-62-1 ( Induced pluripotent stem cell line )

    Ventricular tachycardia
    dbGaP iPSC UUID: 55b460bcb58e4e469f359770f05b165b

  • UCSD059i-63-1 ( Induced pluripotent stem cell line )

    Atrial Fibrillation
    dbGaP iPSC UUID: 68bccd4f3531428eb47df6eaa4512d7b

  • UCSD060i-64-1 ( Induced pluripotent stem cell line )

    Premature ventricular contractions
    dbGaP iPSC UUID: 5e96f9e12a14499791c36a43c43de1c6

  • UCSD061i-65-1 ( Induced pluripotent stem cell line )

    Congestive heart failure, Duchenne's muscular dystrophy
    dbGaP iPSC UUID: 00cfe6afa475436f89dfd25416545734

  • UCSD062i-66-1 ( Induced pluripotent stem cell line )

    Long QT Syndrome
    dbGaP iPSC UUID: 9f47bc0cbf5043efa9d2ea44415cfb78

  • UCSD063i-20-1 ( Induced pluripotent stem cell line )

    Narrow angle glaucoma
    dbGaP iPSC UUID: a3ff3d4e44c84b29b97811dedfa462dd

  • UCSD064i-20-2 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: d9644b8439d64a5091bd26e1adea72bf

  • UCSD065i-20-3 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: 1448a1ac8fd44b81b465f3762e10c4e9

  • UCSD066i-67-1 ( Induced pluripotent stem cell line )

    Thyroid cancer
    dbGaP iPSC UUID: a1e36b2172944c0694a1b6af038b4b14

  • UCSD067i-19-1 ( Induced pluripotent stem cell line )

    Hypothyroidism
    dbGaP iPSC UUID: 48524ebf3be54872b7a85423fe105f69

  • UCSD068i-19-2 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: d73ba98d276549a29142735fca6f233f

  • UCSD069i-19-3 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: 0e7ec423d475476bbd886c8b0eea0d6c

  • UCSD070i-1-1 ( Induced pluripotent stem cell line )

    High cholesterol, previously hypothyroid
    dbGaP iPSC UUID: ee4a12081cec479b803fc4a76935b27e

  • UCSD071i-1-2 ( Induced pluripotent stem cell line )

    High cholesterol, hypothyroidism
    dbGaP iPSC UUID: a35cd47edea5442b8bad419c5bdce1c2

  • UCSD072i-1-3 ( Induced pluripotent stem cell line )

    Non-affected Control
    dbGaP iPSC UUID: f88baccb5da947f5b9e4884c20396013

  • UCSD073i-1-4 ( Induced pluripotent stem cell line )

    Amnesia, thyroid problems
    dbGaP iPSC UUID: 7832f778fa394e16a9d900549e6404dc

  • UCSD074i-1-5 ( Induced pluripotent stem cell line )

    Overactive thyroid
    dbGaP iPSC UUID: 5fa443b8474c45dda96999825b76649c

  • UCSD075i-1-6 ( Induced pluripotent stem cell line )

    Non-affected Control
    dbGaP iPSC UUID: cb94c4634ea745d18549e707a36ebfe7

  • UCSD076i-1-7 ( Induced pluripotent stem cell line )

    Non-affected Control
    dbGaP iPSC UUID: fe571d08a1214ea29512fc78504d4849

  • UCSD077i-1-8 ( Induced pluripotent stem cell line )

    Non-affected Control
    dbGaP iPSC UUID: 91c2b2f30bd94bf181d375c83284ad41

  • UCSD078i-1-9 ( Induced pluripotent stem cell line )

    Non-affected Control
    dbGaP iPSC UUID: 44f1fcf10c1549f2b442e53ddf70fa7c

  • UCSD079i-1-12 ( Induced pluripotent stem cell line )

    Non-affected Control
    dbGaP iPSC UUID: fc9f310ee4c348eb93241044ac8a542c

  • UCSD080i-1-13 ( Induced pluripotent stem cell line )

    Tumor in colon
    dbGaP iPSC UUID: c27a36fe21364e5ba7160fc283bf7911

  • UCSD081i-1-14 ( Induced pluripotent stem cell line )

    Non-affected Control
    dbGaP iPSC UUID: da7063aaaab040708a61885aae4f6df9

  • UCSD082i-40-1 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: a7ba471590e64187888ddbfc3b124809

  • UCSD083i-40-2 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: 8c1dcddd184b4e62a7e1fa3407fd58cb

  • UCSD084i-6-1 ( Induced pluripotent stem cell line )

    Asthma
    dbGaP iPSC UUID: e550facf292347dda740d935a5980b55

  • UCSD085i-6-2 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: 56afbe469f9442d18c3641acfcc08b99

  • UCSD086i-6-3 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: 11c5018bc97549178e97975c9308aa0c

  • UCSD087i-6-4 ( Induced pluripotent stem cell line )

    Asthma
    dbGaP iPSC UUID: 58573de05e654bf88f207c252b8d1cce

  • UCSD088i-6-5 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: 734276c8176c49cc8557db38fa35419c

  • UCSD089i-15-1 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: 6cdb00f363dd4f749e9bd1be890246b8

  • UCSD090i-15-2 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: f6c06de6f49f4c559beff7fceaacc8de

  • UCSD091i-15-3 ( Induced pluripotent stem cell line )

    Type I Diabetes
    dbGaP iPSC UUID: ebabafed6acd4fd28d93b926cf9725f2

  • UCSD092i-1-10 ( Induced pluripotent stem cell line )

    Non-affected Control
    dbGaP iPSC UUID: 55b4f1c03ff9493999c776dda41c9e5b

  • UCSD093i-1-11 ( Induced pluripotent stem cell line )

    Non-affected Control
    dbGaP iPSC UUID: c1a0b73e2e14462696073b9c5aba7808

  • UCSD094i-25-1 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: 8a3c76df480743ad98a67eeeadcb2217

  • UCSD095i-25-2 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: 1883271f923049afaab1474fb3df3d6a

  • UCSD096i-34-1 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: 73eeae9cff9545499795ce2289384bae

  • UCSD097i-34-2 ( Induced pluripotent stem cell line )

    Hypothyroidism
    dbGaP iPSC UUID: ecd93603e54e43d7bbc5b818dd381bde

  • UCSD098i-35-1 ( Induced pluripotent stem cell line )

    GERD
    dbGaP iPSC UUID: f09a3e1ef3ff41bc93a989703c18e280

  • UCSD099i-35-2 ( Induced pluripotent stem cell line )

    Hypothyroidism, high cholesterol
    dbGaP iPSC UUID: 430fea8b9269454d9f0db226b9a676d8

  • UCSD100i-36-1 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: 2e3549799ef0461f9ea49878d69ea218

  • UCSD101i-36-2 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: 3ebafd49b3194faba1315ce779ba0899

  • UCSD102i-2-1 ( Induced pluripotent stem cell line )

    Long QT Syndrome (Type II)
    dbGaP iPSC UUID: 7da656c17c7d4f05bebd0aa20e2bdc16

  • UCSD103i-2-2 ( Induced pluripotent stem cell line )

    Long QT Syndrome
    dbGaP iPSC UUID: 47adb126a87f456b94fae30910bd1d9e

  • UCSD104i-2-3 ( Induced pluripotent stem cell line )

    Long QT Syndrome, Seizure
    dbGaP iPSC UUID: 8cf89b6100ed48dc96fac1680f3ff799

  • UCSD105i-2-4 ( Induced pluripotent stem cell line )

    Non-affected Control
    dbGaP iPSC UUID: 81975dc1298849c58487a528f99c25f3

  • UCSD106i-2-5 ( Induced pluripotent stem cell line )

    Long QT Syndrome, Seizure disorder
    dbGaP iPSC UUID: 8730a13b4957463f94e49ee2a0d99c2d

  • UCSD107i-2-6 ( Induced pluripotent stem cell line )

    Non-Hodgkin's Lymphoma
    dbGaP iPSC UUID: 1301732aae7449ee9bc665d1d41051ce

  • UCSD108i-2-7 ( Induced pluripotent stem cell line )

    Long QT Syndrome, High cholesterol
    dbGaP iPSC UUID: 4a9c0b93d8974d678559396b38e97b1f

  • UCSD109i-2-8 ( Induced pluripotent stem cell line )

    Asthma, celiac disease
    dbGaP iPSC UUID: 8160a823c38945a4ae659ab4d98e31ca

  • UCSD110i-2-9 ( Induced pluripotent stem cell line )

    Non-affected Control
    dbGaP iPSC UUID: 82f970b5d49d4b3cbd79a776c9b78eef

  • UCSD111i-2-10 ( Induced pluripotent stem cell line )

    Non-affected Control
    dbGaP iPSC UUID: 840e9950bad942b9b8104a8a15276cb9

  • UCSD112i-2-11 ( Induced pluripotent stem cell line )

    Non-affected Control
    dbGaP iPSC UUID: bd4b84099e564ca0bcf19e3f61a4de13

  • UCSD113i-68-1 ( Induced pluripotent stem cell line )

    Hypertrophic cardiomyopathy 5 years prior, ventricular arrythmias
    dbGaP iPSC UUID: 292419e565d0456fb4bb643f20c6677c

  • UCSD114i-69-1 ( Induced pluripotent stem cell line )

    Atrial fibrillation, congestive heart failure, COPD
    dbGaP iPSC UUID: 61fbcaede4f046d4b9ec9fca3b1f1afa

  • UCSD115i-70-1 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: 329475afc47e4bce8c535fb72d374150

  • UCSD116i-71-1 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: 4534e0734caf433cacaa03a270fa9bb4

  • UCSD117i-72-1 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: 754a91dca2e944f9a21b9536e2bc453d

  • UCSD118i-38-1 ( Induced pluripotent stem cell line )

    Prostate cancer previously
    dbGaP iPSC UUID: f03b06367826443a8da007a207e826aa

  • UCSD119i-38-2 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: 2acdaca106794ee78f10728eff55fd02

  • UCSD120i-39-1 ( Induced pluripotent stem cell line )

    Left ventricular non-compaction, congestive heart failure
    dbGaP iPSC UUID: 79630ab28a7d463894cc44ade50197be

  • UCSD121i-39-2 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: d0c29527bcd04ebcbc8e66276e3d02f4

  • UCSD122i-73-1 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: 736c51b084a84466a19efe23e99b95d8

  • UCSD123i-74-1 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: 049719b5bf8e489582d0d9dccf2901ea

  • UCSD124i-7-1 ( Induced pluripotent stem cell line )

    Glaucoma
    dbGaP iPSC UUID: b2c39ddc1f9f4eada3ad4324d05e4981

  • UCSD125i-7-2 ( Induced pluripotent stem cell line )

    COPD
    dbGaP iPSC UUID: b0267363e81d4d749b23690abbc5030d

  • UCSD126i-7-3 ( Induced pluripotent stem cell line )

    High cholesterol, diabetes
    dbGaP iPSC UUID: fdb193eecc1242a79e1014ed0fb854e8

  • UCSD127i-7-4 ( Induced pluripotent stem cell line )

    High cholesterol
    dbGaP iPSC UUID: 09678d311af944829d71bcdfdc37c0a1

  • UCSD128i-7-5 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: 32da9e0573734636b4297e50bf42dba2

  • UCSD129i-75-1 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: 3cc054a79bea400f8af308ff8265a5e9

  • UCSD130i-76-1 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: 3981cefd8d5d4319a2fe608ea87499fe

  • UCSD131i-77-1 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: 9a5bda14e01441119f4233d223d25763

  • UCSD132i-78-1 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: f3b46d41ae7941589a69314b2462be4d

  • UCSD133i-79-1 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: 98d311ef15b741f0be5169ce9ead7044

  • UCSD134i-80-1 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: 035af887d7c0416c9b8f7f1390f6ba8c

  • UCSD135i-81-1 ( Induced pluripotent stem cell line )

    Low thyroid, hypertension
    dbGaP iPSC UUID: 89c31202b6d64d04ab5d8608a9e21139

  • UCSD136i-82-1 ( Induced pluripotent stem cell line )

    Atrioventricular block
    dbGaP iPSC UUID: 8f0fa72886a14579adee64dc8415f682

  • UCSD137i-83-1 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: eda9efa6cda8468fb56d1f5a7a43b80b

  • UCSD138i-84-1 ( Induced pluripotent stem cell line )

    High cholesterol
    dbGaP iPSC UUID: 812d9433e25c4227bf95f9ea0852ee53

  • UCSD139i-85-1 ( Induced pluripotent stem cell line )

    Crohn's Disease
    dbGaP iPSC UUID: 40c704f28e5644c5ae729d492e0899ea

  • UCSD140i-37-1 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: 85893f770f08486aadd7aadb4ade35c4

  • UCSD141i-37-2 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: 2fde7b423484475c984d6d3dae5c1159

  • UCSD142i-86-1 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: 10a12f53eb1f4825b2b55609e0085fd4

  • UCSD143i-87-1 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: cf6f9f699cd24fc98f395151dd362f2e

  • UCSD144i-88-1 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: 39463d3b38684539a76fb9d214dffd4b

  • UCSD145i-89-1 ( Induced pluripotent stem cell line )

    Atrial fibrillation
    dbGaP iPSC UUID: 7d5dface9b574d96a2f5588e53a1a117

  • UCSD146i-10-1 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: 599828182da5493fa84eed39eac11a3a

  • UCSD147i-10-2 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: 04feea1a3844496fba12a70792a615de

  • UCSD148i-10-3 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: bb62c80354b84c08a3a348a73a184329

  • UCSD149i-10-4 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: a1b9841ecfb642c9967795961b838b02

  • UCSD150i-11-1 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: 2c61fd82f374462fbbc00eb208d2db1a

  • UCSD151i-11-2 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: 0e2317c22bd94ba09d918a5ea16a6a76

  • UCSD152i-11-3 ( Induced pluripotent stem cell line )

    Endometriosis
    dbGaP iPSC UUID: a118dd3167aa43ba9633758bfff68c4c

  • UCSD153i-11-4 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: 8f1b4e3672e643a5a16e4f733cc2c467

  • UCSD154i-90-1 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: 49e3ad187a1d4a25ba1fd1e23e0f9759

  • UCSD155i-12-1 ( Induced pluripotent stem cell line )

    Long QT Syndrome, Generalized anxiety disorder
    dbGaP iPSC UUID: 04973ac0eb5b47b98c73a568bda368e7

  • UCSD156i-12-2 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: eec852c1e04b4b95ac599f48aa76e175

  • UCSD157i-12-3 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: 0ab72627d0c545dc987c4a9b38c86c7c

  • UCSD158i-12-4 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: 1a31c8a3ee0544f5a27b23c32ce037fb

  • UCSD159i-91-1 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: 7a1ea1ca424342fdbdb84cad314a3d38

  • UCSD160i-92-1 ( Induced pluripotent stem cell line )

    Chronic sinus infections
    dbGaP iPSC UUID: 953ba56b64f3468a96657e24face28bd

  • UCSD161i-93-1 ( Induced pluripotent stem cell line )

    Diabetes mellitus, thyroid removed
    dbGaP iPSC UUID: 5e0ed1ff71fe4c509a23cfb62fa86a5e

  • UCSD162i-94-1 ( Induced pluripotent stem cell line )

    Cardiomyopathy (Hypertrophic)
    dbGaP iPSC UUID: 0c7f8f20fb8a49ab9c3ece7cee9fa3a2

  • UCSD163i-95-1 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: e38cfd59f0a543cdbc4b7e8fc2921c48

  • UCSD164i-96-1 ( Induced pluripotent stem cell line )

    Low thyroid, schizophrenia
    dbGaP iPSC UUID: 464ff0570f0a42ffadd119c0ee0f671a

  • UCSD165i-97-1 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: 3c6051059b504f36add3634021cceac8

  • UCSD166i-98-1 ( Induced pluripotent stem cell line )

    Crohn's Disease, asthma
    dbGaP iPSC UUID: 3d29f82b257f4f2f8d1c5f9a4d5ebf34

  • UCSD167i-99-1 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: 60f4798a271445509afe901c32feacc3

  • UCSD168i-22-1 ( Induced pluripotent stem cell line )

    High cholesterol
    dbGaP iPSC UUID: 6459b28f482d4bc0b2e6e3a47ce4eb4c

  • UCSD169i-22-2 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: 65b9da4ad7a646e18e901adf58bad3e6

  • UCSD170i-22-3 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: 46116d998093453dab160d6da179d76e

  • UCSD171i-100-1 ( Induced pluripotent stem cell line )

    Lyme disease
    dbGaP iPSC UUID: 61c3fda2e24c4aee81accec9fa724ca6

  • UCSD172i-101-1 ( Induced pluripotent stem cell line )

    Atrioventricular block
    dbGaP iPSC UUID: 6196047751774ff8b728ee27951667db

  • UCSD173i-18-1 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: 56f290a31980430f97e0591537e46e41

  • UCSD174i-18-2 ( Induced pluripotent stem cell line )

    Diabetes, GERD
    dbGaP iPSC UUID: 68cccf78717f405897ea79f86ef24406

  • UCSD175i-18-3 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: 05ed8fa9b5af465687af194ab6c52c6a

  • UCSD176i-17-1 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: ddc21ef7fd194fd1bcb12e83b243c9ee

  • UCSD177i-17-2 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: b3b0b16a27364ab5b6819d5300a20ce7

  • UCSD178i-17-3 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: 6ce9cf7affe746f38d2902743bf300f6

  • UCSD179i-27-1 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: 235a5deb085d45aeb17ee4289f1986e9

  • UCSD180i-27-2 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: 328569b5424c4d0d9956a340d9f76792

  • UCSD181i-3-1 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: ec609d97460e4d9f8ba76ca88a06ba0e

  • UCSD182i-3-2 ( Induced pluripotent stem cell line )

    Non-affected Control
    dbGaP iPSC UUID: 3717566eae6c4d4c88efe4af1e6af6a9

  • UCSD183i-102-1 ( Induced pluripotent stem cell line )

    High cholesterol
    dbGaP iPSC UUID: 257b1104784c4e9a91eac545853488ca

  • UCSD184i-8-1 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: 724ca23a64aa4c71a9e1cd1914c0eb47

  • UCSD185i-8-2 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: 5ee3ea91e6744724892bcf9d72aa38d7

  • UCSD186i-103-1 ( Induced pluripotent stem cell line )

    Hypothyroidism
    dbGaP iPSC UUID: 681bc182b1d24ce4bbce4dfdd04ca598

  • UCSD187i-104-1 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: 9761416eeb48417c8aa956124e18ebdc

  • UCSD188i-105-1 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: f1e1f65c500944e2a170b4ec138b0b26

  • UCSD189i-28-1 ( Induced pluripotent stem cell line )

    Asthma
    dbGaP iPSC UUID: b0b28bbf3f8d4197a52c2485c43dbd3c

  • UCSD190i-28-2 ( Induced pluripotent stem cell line )

    Hashimoto's thyroiditis
    dbGaP iPSC UUID: a1338d054c2a4830a537d23abb9264b9

  • UCSD191i-13-1 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: 5e9025929c534333bac11fd2bbf4735f

  • UCSD192i-13-2 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: 39602e3d83aa458aa130e7bcd0036afe

  • UCSD193i-106-1 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: 42c5e658e5b64fd49cd9f51ebaf4123d

  • UCSD194i-29-1 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: 0fb22f092a0043c8be99d5adb3532735

  • UCSD195i-29-2 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: f4ddb16621a84ed6a9883398048201f9

  • UCSD196i-30-1 ( Induced pluripotent stem cell line )

    Glaucoma
    dbGaP iPSC UUID: 3b5781f3a29f4adb882c5f570954828d

  • UCSD197i-30-2 ( Induced pluripotent stem cell line )

    Glaucoma
    dbGaP iPSC UUID: d81748605dd646178432e6e4e22c6bd6

  • UCSD198i-23-1 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: 452b2a71139344b582fd6a5bd7df9e84

  • UCSD199i-107-1 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: 452d8788b6f9456f8bc7fd5107243f25

  • UCSD200i-4-1 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: 19a058ec5eb6444dba3d7c93c5108577

  • UCSD201i-4-2 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: c52f8cedef0f448ea86839be9278fb41

  • UCSD202i-108-1 ( Induced pluripotent stem cell line )

    Diabetes
    dbGaP iPSC UUID: 9b01b2517732448a97ca507a14ee2d57

  • UCSD203i-109-1 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: 6a2899c945eb4151b9d991b81f036bde

  • UCSD204i-26-1 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: 86fdd69915e54bd1ac3a939251009f93

  • UCSD205i-110-1 ( Induced pluripotent stem cell line )

    Breast cancer
    dbGaP iPSC UUID: 4cf70d037dd14936beb00820611439cb

  • UCSD206i-31-1 ( Induced pluripotent stem cell line )

    Hepatitis C
    dbGaP iPSC UUID: 89f4973e18a54f6b8194f4e626aa25a3

  • UCSD207i-31-2 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: 50bcd906661a4d999b52c725ca54967f

  • UCSD208i-111-1 ( Induced pluripotent stem cell line )

    Breast cancer (DCIS)
    dbGaP iPSC UUID: bb2f4dadd5844e2fb424448f9bf97252

  • UCSD209i-24-1 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: 80cde3a454984d3c9abbe0d610e23067

  • UCSD210i-112-1 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: 08d24906ece74f2995f9b81ee5984567

  • UCSD211i-32-1 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: 4d08f157602649119d821d6954e23a5f

  • UCSD212i-32-2 ( Induced pluripotent stem cell line )

    Hypothyroidism
    dbGaP iPSC UUID: 56159fd6e4ee4ec6903035dfbee917a3

  • UCSD213i-14-1 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: 7723df7d564b4243bda170f8afc7d731

  • UCSD214i-14-2 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: 0d6f5378587d43d39ce2d54e3772bdef

  • UCSD215i-113-1 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: ffbb06de45fc4f6688764a982e306926

  • UCSD216i-114-1 ( Induced pluripotent stem cell line )

    Glaucoma
    dbGaP iPSC UUID: c98e03b8c71e4ee58f7ff970119753a8

  • UCSD217i-115-1 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: 8e038c41893e43cc937c9bdb16798af4

  • UCSD218i-116-1 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: bfcaa483134a49988cafb535e511f7d0

  • UCSD219i-117-1 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: 00d0efe1b7e1484e890fc332a1c4002b

  • UCSD220i-118-1 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: 92afe1697bcb4301a18b8b145cca5aec

  • UCSD221i-119-1 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: a47700c9a3624dc08f03b2c263ec8c17

  • UCSD222i-120-1 ( Induced pluripotent stem cell line )

    Non-affected
    dbGaP iPSC UUID: 4b22ae87b05e4292b1b72bc42793efc9

  • UCSD223i-NDC1-1 ( Induced pluripotent stem cell line )

    Non-Demented Control

  • UCSD224i-NDC1-2 ( Induced pluripotent stem cell line )

    Non-Demented Control

  • UCSD225i-NDC1-3 ( Induced pluripotent stem cell line )

    Non-Demented Control

  • UCSD226i-NDC2-1 ( Induced pluripotent stem cell line )

    Non-Demented Control

  • UCSD227i-NDC2-2 ( Induced pluripotent stem cell line )

    Non-Demented Control

  • UCSD228i-NDC2-3 ( Induced pluripotent stem cell line )

    Non-Demented Control

  • UCSD229i-SAD1-1 ( Induced pluripotent stem cell line )

    Sporadic Alzheimer Disease

  • UCSD230i-SAD1-2 ( Induced pluripotent stem cell line )

    Sporadic Alzheimer Disease

  • UCSD231i-SAD1-3 ( Induced pluripotent stem cell line )

    Sporadic Alzheimer Disease

  • UCSD232i-SAD2-1 ( Induced pluripotent stem cell line )

    Sporadic Alzheimer Disease

  • UCSD233i-SAD2-2 ( Induced pluripotent stem cell line )

    Sporadic Alzheimer Disease

  • UCSD234i-SAD2-3 ( Induced pluripotent stem cell line )

    Sporadic Alzheimer Disease

  • UCSD235i-SAD2-4 ( Induced pluripotent stem cell line )

    Sporadic Alzheimer Disease

  • UCSD236i-APP1-1 ( Induced pluripotent stem cell line )

    Familial Alzheimer Disease

  • UCSD237i-APP1-2 ( Induced pluripotent stem cell line )

    Familial Alzheimer Disease

  • UCSD238i-APP1-3 ( Induced pluripotent stem cell line )

    Familial Alzheimer Disease

  • UCSD239i-APP2-1 ( Induced pluripotent stem cell line )

    Familial Alzheimer Disease

  • UCSD240i-APP2-2 ( Induced pluripotent stem cell line )

    Familial Alzheimer Disease

  • UCSD241i-APP2-3 ( Induced pluripotent stem cell line )

    Familial Alzheimer Disease


Web Links:

Last updated: 2016-08-15T11:32:55.355-05:00

Copyright © 2016 by the President and Fellows of Harvard College
The eagle-i Consortium is supported by NIH Grant #5U24RR029825-02 / Copyright 2016